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ABSTRACT 
The study of central nervous system influences on 
energy balance has been dominated by the ventromedial 
hypothalamic (VMH) "satiety center" and lateral hypothalamic 
(LHA) "feeding center" concepts which arose largely from 
the dramatic effects on food intake and weight following 
electrolytic lesions of those structures. The aim of 
this thesis is to resynthesize the hypothalamic feeding 
data, concentrating on VMH functioning, within a framework 
of the role of that structure in glucoregulation. 
In the introduction results are summarized which 
focus on the failure to show any deficit in "satiety" fol-
lowing VMH destruction. This is contrasted with the in-
creasing evidence for autonomic and, in particular, VMH 
influence on visceral organs critical to glucoregulation. 
The reliance of the VMH syndrome on abnormal insulin secre-
tion is highlighted. 
In Chapter Two, three experiments explore the depen-
dence of both VMH and LHA lesion syndromes on nervous con-
nections with the viscera. V1v1H hyperphagia, hyperin-
sulinemia and accelerated weight gain are shown to depend on 
the vagus for ·their expression. The hypophagia, hypodipsia 
and weight loss of the LHA syndrome are shown not to depend, 
in any simple way, either on intact pa rasympathetic or 
sympathetic nervous connections with the viscera. 
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Chapter Three attempts to provide a link between 
studies which show that manipulations of the VMH have 
pronounced effects on the functioning of visceral struc-
tures critical to energy supply and those showing that 
alterations in insulin and glucose availability at the VMH 
influence firing patterns of certain neurons of that struc-
ture. In a series of 4 experiments it is shown that 
insulin has marked hypoglycemic effects when applied direc-
tly to the VMH; that this effect is not an artifact of 
diffus_ion into the ventricles; that the hypoglycemic res-
ponse is even larger in diabetic animals and thus probably 
reflects an integrated metabolic pattern, including at least 
the pancreas and liver, facilitating glucose disposal; and, 
finally, that this series of metabolic events is at least 
partially mediated by the vagus. 
The major findings of Chapters Two and Three are 
then: (1) the reversal of the VMH electrolytic lesion 
effect by vagotomy, and (2) the direct hypoglycemic effects 
of an increase in insulin levels within the VMH, together 
suggesting a glucoregulatory role for the VMH based on 
direct nervous innervation of the viscera. Based on these 
results and on the existing observations of V1H-insulin-
glucose relations, the dynamics of hypothesized VMH insulin-
glucoreceptors are specified. They are seen to be spon-
taneously active, suppressed by insulin, and activated by 
xv 
glucose (but only in the presence of insulin). These re-
ceptors, in concert with others responsive to sensory 
information, are seen to stabilize blood glucose levels: 
(1) by initiating an integrated series of metabolic events 
which act to facilitate glucose disposal in anticipation of 
the initiation of a meal, and (2) by suppressing or re-
versing the same (or similar) set of metabolic events fol-
lowing the meal to avoid a hypoglycemic overshoot. The 
primary role of the VMH is thus seen as one of stabilizing 
glucose supply to the brain. It is hypothesized that the 
major "deficit" following a VMH lesion is the failure to 
suppress the reactive phase of insulin secretion, thus 
inducing a postprandial hypoglycemia and entraining the 
vicious circle of intake to counter the hypoglycemia which 
only serves again to overstimulate insulin. Arguments for 
a central VMH role 1n long-term regulation of body weight 
are countered, and it is suggested that the weight at which 
any particular VMH-lesioned animal stabilizes merely reflects 
the degree of impairment of VMH suppression of reactive 
insulin secretion in concert with the increasing insulin 
resistance attendant upon obesity. Finally, in this chap-
ter, the relation of palatability to the VMH syndrome is 
discussed. 
Chapter Four tests the predictions of the VJvlH insulin-
glucoreceptor model in two areas which have been traditional 
XVl 
problems for the "glucostatic" theory of feeding: diabetic 
hyperphagia and adrenaline anorexia. The duration of the 
initial hypophagic period following induction of diabetes 
1s seen to depend on the energy reserves of the animal and 
it is argued that: (a) hypophagia is the natural result of 
diabetes hyperglycemia, and (b) the onset of hyperphagia 
reflects the influence of a long-term energy depletion 
signal. Adrenaline anorexia follows as a natural conse-
quence (in terms of the VMH insulin-glucoreceptor model) 
of the hyperglycemia-hypoinsulinemia. This view is rein-
forced in the first of a series of 3 experiments which 
demonstrate the absence of the anorexia phenomenon in 
diabetic animals. The second and third experiments rule 
out peripheral theories of adrenaline anorexia by demon-
strating the phenomenon 1n both vagotomized and sympathec-
tomized animals. It 1s suggested that feeding may be used 
as a glucoregulatory device in emergencies and, in such 
situations, the· VMH is involved in con tro 11 ing food in take. 
However, under normal circumstances neither the VMH nor 
blood glucose-insulin levels are likely to influence feeding. 
Much of the theorizing about VMII function has been 
based on the crude electrolytic lesion technique. In 
Chapter Five an attempt is made to identify a naturally 
occurring "VMH syndrome". To this end the hyperphagia and 
increased weight gain attendant upon diestrus in the female 
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rat is studied. The results of a series of 4 experiments 
are negative. The estrus cycle is found not to parallel 
the VMH syndrome, in that insulin levels, high in VMH-
lesioned animals, are found to be depressed during dies-
trus, the period of maximal weight gain. In addition, 
vagotomy, which reverses VMH hyperphagia and weight gain, 
does not affect the rhythmic weight fluctuations of the 
estrus cycle. The results not only disconfirm the relative 
hyperphagia and weight gain of the estrus cycle as a model 
of the VMH syndrome but call into question assertions of 
the relationship between insulin and weight regulation. 
Finally, the glucoregulatory model of VMH function 
is seen to have direct relevance to three areas of clinical 
importance. In Chapter Six the implications of the model 
for diabetes mellitus are explored. The model predicts the 
combination of hyperglycemia and hypoinsulinemia in the 
diabetic will generate a hi gh level of activity in the VMH 
insulin-glucoreceptors and result in a counterproductive 
set of metabolic reactions (i.e., suppression of any resi-
dual insulin secreting capacity, augmented hepatic glucose 
output and increased free fatty acid efflux) . The contri-
bution of a postulated chronic sympathetic nervous system 
(S S) arousal to the metabolic disturbances of diabetes 
mellitus is judged in a series of 4 experiments. n in-
crease in the efficiency of intake utilization, a decrease 
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in blood glucose, and reduced efflux of free fatty acids 
from fat are all seen following SNS destruction in 
diabetes. The results encourage further elucidation of the 
role of the SNS in diabetes. 
In Chapter Seven (Discussion) two further matters 
of clinical importance are discussed in light of the 
glucoregulatory model of VMH functioning. These are: 
(1) neurogenic control of weight regulation, and (2) intra-
venous feeding and caloric ~egulation. 
CHAPTER ONE 
INTRODUCTION 
Research concerned with the neural control of feeding 
behavior has, over the past 35 years, focussed in particular 
upon the ventromedial and lateral areas of the hypothalamus. 
The results obtained have been the subject of numerous 
extensive reviews [see Anand, 1961; Andersson, 1972; Gross-
man, 1966; 1975; Hoebel, 1971; Mogenson, 1974; Morgane a nd 
Jacobs, 1969; Rabin, 1972; Teitelbaum, 1961], but may be 
summarized as follows. Destruction of the ventromedial 
hypothalamic area (VMH), via either electrolytic [Brobeck, 
Tepperman and Long, 1943; Hetherington and Ranson, 1940] or 
radio frequency [Dahl and Ursin, 1969; Herrero, 1969; 
Hoebel, 1969] lesions, results in hyperphagia and gross 
obesity. This hyperphagia is the result, in free-feeding 
animals, of an increase in the size of the individual meals 
rather than an increase in their number [Thomas and Mayer, 
1968]. Electrical stimulation of the VMH terminates ongoing 
feeding behavior [Anand and Dua, 1955; Larsson, 1954; 
Wyrwicka and Dobrzecka, 1960]. Electrical activity in the 
VMH increases during, and for a period after, feeding and 
decreases during deprivation [Anand, Subberwal, Manchanda 
and Singh, 1961]. Intravenous infusion, or direct applica -
tion, of glucose increases VMH activity [Anand, Chhjn a , 
1 
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Sharma, Dua and Singh, 1964; Oomura, Ono, Ooyama and Wayner, 
1969; see also Oomura, 1973]. 
Conversely, it was noted that similar manipulation 
of lateral hypothalamic area (LHA) activity produces 
strikingly reciprocal results. Thus, lesions of the LHA 
result in anorexia and weight loss [Anand and Brobeck, 1951; 
Morrison, Barnett and Mayer, 1958], while electrical stimula-
tion initiates feeding behavior [see Hoebel, 1969]. Changes 
in levels of electrical activity in relation to meals and 
following intravenous infusion or topical application of 
glucose generally were found to be the inverse of those ob-
served in the VMH [Anand, Chhina, Sharma, Dua and Singh, 
1964; Oomura, Ono, Ooyama and Wayner, 1969; Oomura, Ooyama, 
Yamamoto and Naka, 1967]. 
The concept which evolved from this work was of a 
VMH "satiety" center whose primary function was to terminate 
feeding in response to rising levels of certain blood-borne 
factors which correlated with a satisfactory nutritional 
state in the organism. The VMH was thought to accomplish 
this function via a system of inhibitory fibers projecting 
onto the lateral hypothalamic "feeding" center. In fact, 
placing parasagittal cuts in the region of the hypothesized, 
laterally coursing, inhibitory fibers did result in a 
syndrome much like that following VMH lesions [Albert and 
Storlien, 1969; Gold, 1970; Scalfani and Grossman, 1969]. 
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The wide favor which this model received was due to the 
wealth of consistent data, its pleasing apparent simpli-
city, and, in no small part, to the enormity of the 
feeding and weight effects following electrolytic lesions. 
The primary difficulty in the medial "satiety" area 
segment of this system has been the repeated failure to 
demonstrate any specific satiation deficit following des-
truction of the VMH. Thus, intraperitoneal injections of 
glucose are even more anorexigenic in VMH lesioned cats 
[Russek and Morgane, 1963]. Eating in response to insulin-
induced hypoglycemia is normal [Epstein and Teitelbaum, 
1967]. There is no impairment of postprandial satiety to 
gastric infusion of proteins, carbohydrates or fats fol-
lowing VMH lesions [Panksepp, 1971]; nor any effect of 
similar lesions on solely post-absorptive satiety [Booth, 
Toates and Platt, 1976]. Compensation is nearly perfect 
for the caloric value of glucose infused intragastrically 
[Liu and Yin, 1974] or intravenously [Rowland, Meile and 
Nicolaides, 1975]. Finally, the response to caloric dilu-
tion is unimpaired when palatability is controlled [Smutz, 
Hirsch and Jacobs, 1975]. 
By contrast with this negative evidence, data have 
steadily accrued in support of a central role for the VMH 
in control of visceral organs involved in the handling of 
ingested nutrients, particularly the stomach, liver and 
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pancreas. Among the most relevant of these changes to 
energy balance are the marked hyperinsulinemia in the face 
of only normal blood glucose [Hales and Kennedy, 1964], 
enlargement of pancreatic islets [Han, Yu and Chow, 1970], 
massive accumulation of fat [Hetherington and Ranson, 1940], 
increased gastric acidity [Ridley and Brooks, 1965], in-
creased free fatty acid levels [Hal es and Kennedy, 1964], 
enlarged, "fatty" liver [Brobeck, Tepperman and Long, 1943], 
and decreased growth [Reichlin, 1961] which follow VMH 
lesions. Conversely, electrical stimulation of the VMH 
increases blood glucose while suppressing insulin [Frohman 
and Bernardis, 1971] and depleting liver glycogen [Shimazu, 
Fukuda and Ban, 1966]. The failure of hypothysectomy to 
reverse the VMH effect [see Cox, Kakolewski and Valenstein, 
1968] has moved attention away from pituitary hormones. 
While undoubtedly decreased growth and a reduced basal 
metabolic rate (possibly from a decrease in thyroid func-
tioning) could contribute to th e magnitude of the effect, 
it would appear that insulin is critical to the expression 
of hyperphagia and weight gain following VMH lesions. Cer-
tainly hyperinsulinemia has been consistently shown to 
accompany VMH obesity [see Frohman and Bernardis, 1968; 
Hales and Kennedy, 1964; Hustvedt and L¢v¢, 1972; York and 
Bray, 1972]. Electrical stimulation of the VMH results in 
an increase in blood g lucose and a suppression of the 
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insulin rise which would normally occur in response to the 
induced hyperglycemia [Frohman and Bernardis, 1971]. This 
suppression of insulin may occur indirectly from stimula-
tion of the adrenal medulla [Frohman and Bernardis, 1971] 
and/or directly via neural input to the pancreas [Miller, 
1975]. In addition, the insulin levels seen 48 hours after 
VMH lesions with food intake restricted to normal levels 
correlate highly with the subsequent weight gain observed 
on free feeding [Hustv edt and L¢v¢, 1972]. 
However, a number of problems interfere with estab-
lishing the causality of this relationship. Both hyper-
phagia and obesity themselves result in increased insulin 
levels even in neurally intact animals [Sims, Horton and 
Salans, 1971]. Additionally, VMH-lesioned animals increase 
their food intake primarily by increasing meal size 
[Teitelbaum and Campbell, 1958; Thomas and Mayer, 1968]. 
Normal animals trained to consume their food in large meals 
(versus nibbling) also display increased insulin levels and 
increased fat deposition [Cohn, 1963; Fabry, 1967; Leveille, 
1972]. These considerations have prompted studies in which 
insulin levels were controlled by induction of diabetes. 
York and Bray [1972] and Young and Lui [1965] de-
monstrated the failure of VMH lesions to increase either 
food intake or body weight in animals previously made 
diabetic either with streptozotocin or alloxan. York and 
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Bray [1972] concluded that "an increased circulating level 
of insul[n is required for the appearance of hyperphagia 
and for the progression of obesity resulting from hypo-
thalamic damage of adult female rats". Their conclusion 
has been challenged by both Friedman [1972] and, more 
recently, Vilberg and Beatty [1975]. Both these latter 
studies, however, are marred by a failure to measure resi-
dual insulin-secreting capacities in their animals made 
diabetic by alloxan [Friedman] and streptozotocin [Vilberg 
and Beatty]. For instance, it should be noted in the 
Friedman study that his alloxan-diabetic rats had food 
intakes no higher than those of control animals, a finding 
distinctly at odds with earlier results [see Brodsky, Nelson 
and Guest, 1952]. Some recovery of insulin secreting 
capacity (due most probably to hypertrophy of surviving beta 
cells) occurs over time following induction of diabetes 
with streptozotocin. In particular, special care must be 
taken to assess residual insulin-secreting capacity fol-
lowing destruction of an area like the VMH which is closely 
identified with the sympathetic nervous system [Ban, 1964, 
1966]. Sympathetic nervous system arousal is known to 
suppress insulin secretion [see Woods and Porte, 1974; 
Miller, 1975], and destruction of the primarily sympathetic 
VMH might act to remove inhibition of the remaining insulin-
secreting capacity after drug-induced pancreatic beta cell 
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destruction. In this regard the data of York and Bray 
[1972, Table 4] are particularly interesting. They show 
insulin levels in two groups of animals, both made diabetic 
by identical means and both maintained on 2U insulin/100 
grams/day. Assays done on blood sampled 24 hours after the 
last insulin injection showed that the group of animals with 
VMH lesions had insulin levels almost double those of the 
unlesioned control group. 
It would thus seem that the conclusion reached by 
York and Bray [1972] and Young and Liu [1965] must be ten-
tatively accepted until such time as hyperphagia and supra-
normal weight gain can be demonstrated in a group of 
diabetic VMH-lesioned animals whose insulin secretory 
capacity is shown to be equal to unlesioned diabetics. 
In synthesis, insulin would appear to play a central 
role in the VMH syndrome, correlating with, and probably 
being necessary for, the hyperphagia and obesity. The 
primary focus of this thesis is on clarifying the relation-
ship between insulin-glucose regulation and the more 
traditional role seen for the hypothalamus, particularly 
the ventrornedial area, 1n feeding. The first experiments 
(Chapter Two) are aimed at establishing the role of the 
autonomic nervous sys tern in the VMI [ and LHA syndromes. 
Chapter Three provides evidence for a primary VMil role 1n 
glucoregulation and a model is proposed. Chapter Four tests 
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certain predictions generated by the model. Chapter Five 
is an attempt to determine whether the es trus cycle of the 
female rat can be used as a "mini-VMH syndrome" un encum -
bered by the multitude of extraneous metabolic changes 
undoubtedly produced by a lesion in such a central sub-
cortical area. Finally, in Chapter Six, the predictions 
generated by the model of Chapter Three are applied to the 
treatment of diabetes mellitus. 
CHAPTER TWO 
HYPOTHALAMIC-VISCERAL RELATIONSHIPS 
2.1 Introduction 
As summarized in Chapter One, there has been a sub-
stantial accumulation of data demonstrating marked changes 
in the functioning of visceral, energy-re gulating organs 
with alterations in hypothalamic activity and quite con-
vincing evidence that hypersecretion of insulin is critical 
to the expression of hyperphagia and weight gain following 
VMH lesions. The following chapter is aimed at exploring 
the role of autonomic nervous connections with the viscera 
in the alterations of body weight which result from VMH 
and LHA lesions. 
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2.2 Experiment 1: VMH-Vagotomy 
There are numerous mechanisms by which the body main-
tains a basal level of insulin secretion [see Goodner and 
Porte, 1972]. The origin of the malfunction following VMH 
lesions is not apparent. The hyperinsulinemia is not a 
secondary result of hyperphagia or pituitary hormone changes. 
Increased plasma insulin ·1evels and hyp er trophy of pancre-
atic islets have been demonstrated in hypophysectomi zed , 
VMH-lesioned animals [Han and Frohman, 1970; Ilan, Yu, and 
Chow, 1970] and in VMH-lesioned animals whose food intake 
has been restricted to control levels [Han, Yu and Chow, 
1970; Hustvedt and L¢v¢, 1972]. In th e absence of altered 
pituitary hormone or of stimulation indirectly resulting 
from .a superabundance of incoming nutrient, th e most likely 
mediating systems for insulin release are the sympathetic 
and parasympathetic components of the autonomic nervous 
system. 
While the mechanism by which the sympathetic nervous 
system modifies insulin release is obscure, a dual role has 
been established. The inhibitory effect of epinephrine on 
insulin release [Porte, Graber, Kuzuya, and Willjams , 1966] 
would appear to result from alpha-adrenergic receptor 
activation (alpha-stimulants inhibit and alpha-blocking 
agents stimulate insulin rel ease) . The reciprocal relation-
ship is true for the beta-adrenergic system with beta-
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stimulants increasing and beta-blockers decreasing insulin 
release [see Porte, 1969, for review]. 
The parasympathetic system may, however, be of 
greater importance to hypothalamic hyperinsulinemia. A 
substantial body of data supports _the importance of para-
sympathetic vagal fibers in neural control of insulin 
secretion. Malaisse, Malaisse-Lagae, Wright, and Ashmore 
[1967] and Kajinuma, Kaneta, Kuzuya, and Nakao [1968] 
demonstrated a rise in insulin levels following infusion of 
acetylcholine and metacholine respectively. Frohman, 
Ezdinli, and Javid [1967] reported a rise in plasma insulin 
following vagal stimulation which could be blocked by the 
parasympathetic blocking agent atropine. These same inves-
tigators reported a fall in plasma insulin following bi-
lateral vagotomy. Conditioned hypoglycemia, which appears 
to be dependent on a conditioned insulin release [Woods, 
Alexander and Porte, 1972], is also abolished by both 
vagotomy and atropine but not by the adrenergic suppressant, 
guanethidine [Woods, 1972]. Finally, Larsson [1954] reported 
electrical stimulation of the brainstem in the area of the 
dorsal motor nucleus of the vagus produced massive hypcr-
phagia. 
If hypothalamic hyperinsulinemia is mediated 
directly via pancreatic vagal innervation, vagotorny should 
reduce insulin levels to control values in VMH-lesioned 
animals. The present experiment was designed to test this 
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possibility. 
2.2.1 Method 
Subjects were female albino rats of between 180 and 
200 grams at operation obtained from the breeding colony of 
the John Curtin School of Medical Research (Canberra, 
Australia). Animals were divided into 3 groups. One group 
(VMH-Vag) received VMH lesions followed 3 weeks later by 
subdiaphragmatic vagotomy. A second group (VMH-Sham) re-
ceived the VMH lesions followed by sham vagotomy. Animals 
in the control group (Sham-Vag) received sham VMH lesions 
followed by vagotomy. All subjects were weighed on the day 
of the VMH or sham lesion, 1 and 2 weeks later, on the day 
of the vagotomy or sham vagotomy, and 4, 7, 11 and 14 days 
following that operation. Blood samples were taken one day 
before the VMH or sham lesion, 1 and 2 weeks following this 
operation, and 1 and 2 weeks following vagotomy or sham 
vagotomy. Food intake was measured for the 24-hour period 
preceding the deprivation prior to each blood sampling. A 
weighed amount of pellets (Mecon Rat Chow) was placed in the 
cage and the remaining pellets weighed again at the end 
of the 24-hour period. Spillage, collected on paper towels 
placed under the individual cages, was air dried. The 
dry weigh t of spilled food was subtracted from the difference 
between the "in" and "out" pellet weights to give a final 
intake figure. Arbitrarily, only VMH-lesioned animals 
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gaining at least 5 times the mean control gain in the 2 
weeks following placement of the lesion were continued into 
the vagotomy phase of the experiment. 
Under Nembutal anesthesia (50 mg/kg) electrolytic 
lesions (2 ma for 15 seconds) were produced bilaterally 
through coated stainless steel electrodes insulated except 
for 0.3 mm at the tip. A tail cathode completed the cir-
cuit. Coordinates [de Groot, 1959] were anterior 6.0 mm, 
lateral ±0.5 mm, and 0.5 mm above the floor of the cranium. 
Operative procedures for control animals were identical 
except that the electrode was lowered only 5.0 mm from the 
dura and no current was passed. Penicillin (50,000 U/day) 
was injected i.m. for two days post-operatively. 
Bilateral subdiaphragmatic vagotomy was also carried 
out under Nembutal anesthesia (50 mg/kg). An incision was 
made caudal from the xiphisternum approximately 2 cm in 
length. Under a 20 power dissection microscope, the 
esophagus was located and lifted from the body cavity on a 
pair of small forceps, care being taken to avoid damage to 
the liver. The vagi were located and at least 3 to 4 mm of 
each nerve was cut loose and removed. All traces of nerve 
tissue were cleared while avoiding damage to tJ1e musculature 
of the esophagus or blood supply to the stomach . The muscle 
wall was repaired with silk sutures and the wound closed 
with Michel wound clips. The wound ar-ea was liberally 
covered with Cicatrin (Calmic Pharmaceuticals, Australia) 
and penicillin injected i.m. (50,000 U/day) for 3 days 
following the operation. Sham operations were identical 
with the exception of the actual severing of the vagi. 
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All blood sampling was done by slitting a tail vein 
under light ether anesthesia. The time from initiation of 
ether to completion of blood sampling was ab out 3 to 4 
minutes. Blood sampling was done between 1400 and 1500 
hours to avoid diurnal variation [Jolin and Montes, 1973] 
on 6- to 7-hour deprived animals. Following collection, all 
samples were immediately centrifuged and the plasma stored 
at -18°C for later insulin analysis. 
Insulin was assayed by the double antibody radio-
immunoassay technique. No rat standard was available so 
insulin is expressed in terms of hum an standard. 
Following completion of the experiment, the animals 
were killed and the brains of experimental animals were re-
moved, hardened in 10 % formalin and sectioned at 50 microns. 
Every fourth section was stained with thionin to localize 
the lesion site. This was done only to confirm that the 
lesions included extensive bilateral damage to the VMII with-
out substantial dama ge to surrounding structures. 
In addition, the esophagus of each animal was also 
removed at sacrifice and examined under a microscope for 
evidence of intact neural ti ssue . This was the only test 
made for completeness of vagotomy and was done completely 
blind. Minimal regrowth had taken place and traces of 
intact tissue were found in only 3 animals. These were 
omitted from the analysis. 
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Statistical analysis was done using a one-way, fixed 
effects analysis of variance at selected time points fol-
lowed, where appropriate, by Scheff§ individual comparisons. 
2 . 2 . 2 Results 
Data are summarized in Figure 1 (see Appendix A for 
the F ratios). The major result is the effect of vagotomy 
on animals with prior lesions of the VMH (VMH-Vag group). 
These animals, selected on the basis of their post-lesion 
weight gain, all displayed, in addition, highly significant 
hyperphagia (p < .001, 1 and 2 weeks following the lesion) 
and hyperinsulinemia (p < .05 and p < .01, respectively, 1 
and 2 weeks following the lesion). 1Veight, insulin level 
and food intake in this group all dropped markedly following 
vagotomy. By 2 weeks post-vagotomy, ther e were no sig-
nificant differences on any measure between V 111-Vag (n = 7) 
and Sham-Vag (n = 8) groups (p > . 20 in all cases) while 
both the s e gr o ups d if fer e d on a 11 me a s u r c s [ r om th c VM I I -
Sham (n = 8) group (p < .01 in all cases). It is interes-
ting to note that although food intake 1 week post-vagotomy 
in the 1H-Vag group was significantly less (p < . 01) than 
that of the Sham-Vag group, insulin levels were still 
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Figure 1. The effect of VMII lesions followed 
by Vagotomy (•) on measures of plasma insulin, 
food intake and body weight. VMH lesion-sham 
vagotomy (o) and sham lesion-vagotomy (x) groups 
are included for comparison. 
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elevated (p < .05). This may reflect an insulin resis-
tance in the VMH-vag group resulting from a higher mean 
body weight (p < .05) and, presumably, lar ge r fat cells. 
2.2.3 Discussion 
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The present results demonstrate th e dependence of th e 
hyperinsulinemia following VMH lesions on parasympathetic 
vagal connections with the viscera. During the course of 
this study Powley and Opsahl [1974] reported results of a 
similar study which confirm the present results with respect 
to weight loss following vagotomy in VMII lesioned animals 
and further show a reversal of the excess gastric acid 
secretion which also results from V1H lesions. 
It is entirely possible that V1H lesions result in 
primary hypersecretion of gastric acid (and th en gas tro-
intestinal hormones) as well as insulin in an integrated 
pattern of visceral activity. Alternatively, oversecretion 
of one may drive the output of the other. The effect of 
insulin on secretion of gastric acid is bo th large and the 
findings consistent [see for example Farooq and Isenberg, 
1975]. The reverse effect would appear less supported 
[Fajans and Floyd, 19 72 ]. It would seem, therefore, more 
likely that the amelioration, followin g vagotomy , of the 
hyperinsulinemia explains the present data as well as that 
of Powley and Opsahl [19 74 ]. 
From the results of the present expe riment nothing 
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can be said about exactly how the oversecretion of insulin 
comes about after VMH destruction. However there are a 
number of existing results which provide clues to this 
process and it may be worth examining them at this point. 
On available evidence it would seem that destruction of the 
VMH is not a sufficient condition for hyperinsulinemia. 
Frohman, Goldman, Schnatz and Bernardis [1972] were able to 
demonstrate normal insulin levels in VMH-lesioned animals 
following a 48-hour fast. Further, Martin, Konijnendijk 
and Bouman [1974] and Trevethan [1972] restricted both their 
VMH-lesioned and control animals to 67% [Martin, Konijnendijk 
and Bouman] and 80 % [Trevethan] of normal control intake. 
These studies demonstrate normal basal insulin levels in 
VMH-lesioned animals thus maintained. Louis-Sylvestre [1971] 
reported nor~al glucose tolerance curves 24 and 48 hours 
following VMH lesions in animals totall y deprived of food 
during this period. This contrasted with the elevated "K" 
values (indicative of facilitated glucose removal) of VMH-
lesioned animals allowed access to food during this post-
operative period. Steffens, Mogenson and Stevenson [1972] 
found a transient increase in basal insulin levels fol-
lowing VMH lesions which disappeared in their "non-hyper-
phagic'' group (3 animals with histologic a lly verified ex-
tensive bilateral VMH lesions but which, for whatever reason, 
failed to overeat in the immediate post-operative period) . 
Woods, Kaestner and Vasselli (1975] recently indicated 
insulin rises following local anesthesia of the VMH. 
Whether this effect would, as in the study of Steffens, 
Mogenson and Stevenson (1972], also disappear over time 
1s unclear. 
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Basal hyperinsulinemia has certainly been shown to 
occur when VMH-lesioned animals are given amounts of food 
equal to normal consumption [Han and Frohman, 1970; Hustvedt 
and L¢v¢, 1972] and even when this food is tubed intragas-
trically to control completely for meal patterning [Han 
and Frohman, 1970]. Additionally, 1n a similar intragastric 
pair-feeding study, Han, Yu and Chow [1970] demonstrated 
increased pancreatic islet size in VMH-lesioned animals. 
It was, however, also demonstrated by Han and Frohman [1970] 
that on normal amounts of food, fed intragastrically, the 
VMH-lesioned animals accumulate significantly more fa t than 
controls. This observation must mean larger fat cells and 
that may well account for the observed increase in basal 
insulin levels. 
In summary, depriving VMH-lesioned animals for 48 
hours [Frohman, Goldman, Schnatz and Bcrnardis, 1972]; 
restricting their food intake to 67 % [Martin, Konijnendijk 
and Bouman, 1974] or 80% [Trevethan , 1972] of normal control 
intakes; or not allowing access to food for th e 48-hour 
period following placement of the lesion [Louis-Sylvestre, 
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1971] all result in insulin levels in VMH-lesioned animals 
equivalent to similarly treated controls. 
The primary defect following VMH lesions is then 
likely to be not a shift in basal insulin levels but a dis-
inhibition of the stimulated insulin response. It can be 
noted in the study of Martin, Konijnendijk and Bouman [1974] 
that in spite of normal basal levels, stimulated insulin 
release was greater in their VMH-lesioned animals. Th e 
model which is formulated in the general discussion to 
Chapter Three (based largely on the results of this experi-
ment and those of the following chapter) speaks further to 
this point. 
2.3 Experiment 2: LHA-Vagotomy 
The hypopha g ia and weight loss which result from 
electrolytic lesions of the LHA are often seen as reflec-
ting changes along the same continuum as the hyperphagia 
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and weight gain of the VMH syndrome [sec Woods , Decke and 
Vasselli, 1974; Woods and Porte, 197 6 ]. The results of 
Powley and Opsahl [1974] and of the previous experiment have 
demonstrated the importance of vagal connections with the 
viscera 1n the etiology of the VMI I syndrome . The reciprocal 
effects of VMH and LHA stimulation on blood glucose 
[Frohman and Bernardis, 1971; Shima zu, Fukuda and Ban , 
1966], liver enzyme activity [Shim azu and Ogasawara , 1975; 
Shimazu, Fukuda and Ban, 1966], and gastric secretion 
[Misher and Brooks, 1966] fur ther reinforce the possibility 
that whatever the nature of the visceral change induced by 
VMH lesions, and reversed by vagotomy, a change in the op-
posite direction may result f rom LIIA lesions. 
Initial results appeared to support thjs s t and . Snow-
don and Wampler [1974] reported a reversal, by vagotomy , of 
the food intake depression which results from LHA lesions. 
This result, however, is in contrast to the more recent 
findings of Powley and Opsahl [1 976 1. [n this study they 
observed the small weight l oss no rmally seen following 
vagotomy in control animals. Vagotomy, in their LHJ\ 
lesioned rats, not onl y failed to ameliorate the weight 
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reduction of this group but resulted in a further weight 
loss greater in magnitude than that observed in the control 
group. It is possible that the differences between the two 
studies can be accounted for in terms of the different 
measures (Snowdon and Wampler measured food intake, while 
Powley and Opsahl measured weight) used to assess the effect 
of vagotomy on the LHA syndrome. 
The present experiment was designed to resolve the 
conflicting evidence by assessing the effect of vagotomy in 
normal and LHA lesioned rats on measures of food intake and 
weight gain. In addition, basal plasma insulin levels were 
measured largely because there is some indication that 
vagotomy may lower blood insulin levels [Frohman, Ezdimli 
and Javid, 1967; Kaneta, Kosaka and Nakao, 1967] and if LHA 
lesions result in a syndrome opposite to that produced by 
VMH lesions then the cumulative effect of both vagotomy and 
LHA lesions may be a detectable hasal hypoinsulinemia. 
2.3.1 Method and Results 
Subjects were male, Wistar-derived rats of between 
300 and 360 grams obtained from the breeding colony of the 
John Curtin School of Medical Research (Canberra, Australia). 
Animals were assigned randomly to 1 of 3 groups. One group 
(LHA-Vag) received LHA lesions followed 4 weeks later by 
bilateral subdiaphragmatic vagotomy. A second group (LHA-
Sham) received the LHA lesions followed by sham vagotomy. 
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The control gr oup (Sham-Vag) received sham lesions followed 
by vagotomy. All subjects ·were weighed on the day before 
LHA or sham lesion, daily until weight gain was seen on 
dry food, and weekly therea f ter. 
Blood samples were t ake n 1 day before LHA or sham 
lesion, 2 weeks following that operation and 2 and 4 weeks 
following vagotomy or sham vagotomy. Food intake was 
measured over a 24-hour period prec eding the 6- to 7-hour 
deprivation prior to each blood sampl e. 
The lesioning procedur e for both experimental and 
control animals were as 1n Expe riment 1. Coordinates [de-
Groot, 1959] were anterior 6.0 mm, lateral ±1. 8 mm, and 8.0 
mm below the dura. A current of 1 ma was passed for 10 
seconds. 
Wet, sweetened food was given following the LHA 
lesions and the animal was hydrated if necessary. When 
weight gain was observed, the wet food was withdrawn and 
reinstituted if fur~her weight lo ss occurred. All animals 
were gaining weight on dry rat chow and plain water by 3 
weeks following the lesion. 
Bilateral, subdiaphragmatic vagotomy, blood sampling 
and insulin assay were all carried out as in Experiment 1. 
One week following t he final blood sampling animals 
were deprived of food for 36 hours and tested for complete -
ness of vagotomy. Basal and insulin-stimulated acid 
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secretion were assessed as follows. Animals were anes-
thetized with sodium pentobarbitol (40 mg/kg i.p.). A 
midline incision was made posterior from the xiphisternum. 
A small cut was made in the duodenum approximately 3 cm 
from the pylorus. A length of polyethylene tubing (P.E. 
240), flared on the end to a diameter o[ 5 mm, was slipped 
into the duodenum. The flared end was pushed through the 
pylorus, drawn back to a snug fit and sutured into place. 
The stomach was flushed with physiologjcal saline warmed to 
37°C until draining clear. A small polyethylene tube (P.E. 
60), also flared at the end, was th en purse-sutured into 
the antrum of the stomach through a smaJ 1 puncture. Five 
mls of warmed physiolo gic al saline were then injectecJ 
through the antral tube each 5 minutes. Fifteen minute 
flow periods were collected from the duodenal cannula and 
titrated with 0.005 N NaOH protected from the atmosphere 
with soda lime. Two 15-minute periods o[ baseline data were 
collected. Insulin (2 U/kg) was then injected subcutane-
ously and 2 further 15 -minute periods o[ acid secretion were 
collected and titrated. A strict criterion for complete-
ness of vagotomy was used; 0cid outpllt 01 e i ther JS - minute 
period following insulin injection was not allowed to 
exceed the output of the mean of the 2 pre-insulin periods. 
Of the 18 vagotomized animals tested, 1 LJ!J\ and 1 Control 
did not meet criterion and were discarded from the experi-
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ment and 1 LHA animal di e d under the anesthetic . 
The animals were th e n killed with ether and the 
brains of the experimental an imals were removed , hardened 
in 10% formalin and sectioned at 50 microns. Every four th 
section was stained with thionin to localize the lesion 
sites. 
Statistical analysis was done using a one -way anal-
ysis of variance with fixed effects fo ll owe d, where appr op-
riate, by Scheffe individual comparisons . 
2.3.2 Results 
Res u 1 ts a r e sh o vm in F i g u re 2 ( F r at i ·o s a r e sum -
marized in Appendix B). Wei ght, in the LHA- l esioned an imals 
(LHA-Vag, n = 7; LHA -Sham, n = 8), dec li ned rapiclly [al-
lowing the operation in the abs enc e of e jther voluntary food 
or water intake. The period of anorexia lasted from 4 to 
7 days and was followed by a gradual increase in intake of 
1 
wet mash, and finally dry food, to the point of sustai ning 
1There have been a numb er of r epor ts focussing on 
various aspects of the LHA -lesioned animal ' s difficulty in 
regulating fluid balance [s ec Epstei 11, 1971 ; Kucharczyk and 
Mogenson, 1976; Rowland and Nicolaides, 19 75 ; Stricker and 
Wolf, 1967]. In the pres ent experiment, 30 animals sus-
tained LHA lesions. Of tho se , 23 reacted wi th anorexia and 
substantial weight loss. Hi s tolo gy clone on the 7 .unsuc-
cessful animals generally confirmed either asymmetrical or 
misplaced lesions. Of th e 23 animals initially retained for 
the experiment, 19 made the transiti on from wet mash to dry 
food and water from tubes within a maximum of 4 or 5 ex-
posures and without apparent undue adverse reaction . They 
maintained, on dry food, a near norma l growth rate but at 
a reduced weight level (Figure 2). These results suggest 
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Figure 2. The effect of LHA lesions followed by 
vagotomy C•) on measures of plasma insulin, food 
intake and body weight. LHA lesion-sham vagotomy 
(o) and sham lesion-vagotomy (x) groups are in-
cluded for comparison. Body weight of the LHA-
Vag group is also expressed as a percentage of 
the Sham-Vag control group. 
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weight gain in all animals by the third week post-lesion. 
The effect of both LHA lesion and subsequent vagotomy on 
body weight is most clearly seen when the weight of the 
LHA-Vag group is expressed as ·a percentage of the Sham-Vag 
control group (lower graph, Figure 2). Following the 
decline during the week following LHA lesion, weight gain 
was then seen at a rate which closely matched that of 
controls over the next 3 weeks. Following vagotomy, weight 
in both LHA-lesioned and control animals declined slowly. 
Although not measured quantitatively, all animals ate and 
drank during the days immediately following vagotomy. The 
vagotomy effect was, if anything, slightly larger in the 
LHA-lesioned group (as can be seen on the Weight (LH/C x 
100) portion of Figure 2). Body weight of the LHA-Vag group 
was lower (at least p < .01 in all cases) than that of the 
Sham-Vag group throughout the 4 weeks following LHA or Sham 
lesion and 4 weeks of observation following vagotomy. 
Food intake of the LHA-Vag group was below that of the 
Sham-Vag (n = 8) group when tested 2 weeks following LHA or 
Sham lesion (p < .01) and 2 and 4 weeks following vagotomy 
that, in general, the LHA lesions produced in the present 
experiment resulted in reduced weight and low intake without 
substantial difficulty in regulating fluid balance. Whether 
these animals would have had difficulty in coping with 
specific, induced hydrore gula tory challenges is not known. 
(p < .01 and p < .05 respectively). 
Basal gastric acid secretion did not differ between LHA-
Vag (2.60±0.91 µE H+/15 minutes) and Sham-Vag (2.83±0.61 
µE H+/15 minutes) groups (p > .20). The F ratio never 
reached significance at any of the 4 insulin measurement 
times (see Appendix B). 
2.3.3 Discussion 
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These results demonstrate that an intact vagus is not 
necessary to sustain either the weight reduction or the 
hypophagia which results from electrolytic lesions of the 
LHA. This conclusion is in agreement with that reached by 
Powley and Opsahl [1976]. Also in agreement with these 
authors, basal gastric acid secretion did not differ 
between vagotomized animals who had previously ei ther sus-
tained an LHA lesion or a sham operation. A reduction in 
gastric acid secretion then appears not to be the cause of 
the reduced level of weight maintenance following LHA 
lesions. 
Neither LHA lesions nor vagotomy had any effect on 
basal insulin levels. This is consistent with the results 
of Steffens, Mogenson and Stevenson [197 2]. Both sets of 
results must be interpreted with caution, however, for two 
reasons. One obvious problem is the use of human insulin 
standard. This may tend to obscure differences depending 
on whether human insulin is more or less reactive than rat 
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insulin with the particular insulin binding agent used. 
Secondly, the differences between LHA-lesioned and control 
animals, if they exist, are obviously small and would re-
quire that the assay be carefully adjusted to maximal sensi-
tivity at the rat's normal basal level of insulin if dif-
ferences are to be detected. 
It is perhaps surprising that in spite of the paral-
lels frequently drawn between the VMH and LHA lesion prepara-
tions, little is know of insulin-glucose relationships 
following LHA manipulations. Electrical stimulation of the 
LHA has been reported to produce an increase in plasma 
insulin [Idahl and Martin, 1971; Kuzuya, 1962; Steffens, 
Mogenson and Stevenson, 1972] and, variously, an increase 
[Natelson, Stokes and Smith, 1972], no effect [Frohman and 
Bernardis, 1971], a decrease [Kurotsu, Tabayashi and Ban, 
1953; Shimazu, Fukuda and Ban, 1966] and a triphasic 
(increase-decrease-increase) change [Booth, Coons and Miller, 
1969] in blood glucose. No interpretable data exist re-
garding the effects of LHA lesions on insulin or glucose 
levels. As pointed out, it is perhaps unreasonable to 
expect a reduction in the already very low basal insulin 
values [present experiment; Steffens, Mo genson and Stevenson, 
1972]. The stimulated insulin levels of this latter study 
are marred by the absence of appropri a te control animals. 
Chlouverakis and Bernardis [19 72] attempted to gather basal 
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data in lean and obese (obob) mice . Unfortunately, fol-
lowing the placement of LHA lesions all the lean mice d i ed . 
Their surviving obese mice showed a pa tt ern of weight 
maintenance at a reduced level for 2 months following th e 
lesions and there is some suggestion of a reduced insulin 
level in these animals; especially in 2 whose weight had 
been reduced prior to surgery . The " obob" mouse does, how-
ever, present an obese-hyp erg lycemi c syndrome and the reduc-
tion of insulin levels may be an indirect result of a 
decrease in glucose levels. Despite the absence of any 
relevant data, reduced insulin levels in LHA-lesioned ani-
mals have been used as a key argument for a causal relation 
between insulin and weight maint enance level [Woods, Decke 
and Vasselli, 1974; Woods and Porte, 1976]. 
Unfortunately, given access to only a human insu l in 
assay set-up (requiring from each rat a substantial amount 
of blood) it was not possible to pursue this point . Proper 
insulin response-glucose toler ance curves are needed for 
both control and LHA-lesione d animals maintaining reduced 
weight levels. The oral procedure employed by Louis-
Sylvestre [19 71 ] as well as the procedure using an i.v . 
bolus of glucose wo ul d provide valuable information. 
It was perhaps unrealistic to anticipate that a 
disruption of p a rasympathetic innervation of the viscera 
hould ameliorate the weight reduction of the LH syndrome. 
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The tonic effect of the vagus on weight and intake occurs 
over the first 2 weeks following vagotomy, probably due to 
gastric stasis and the "dumping 1 ' phenomenon well known 
from human work . However, intake and weight gain soon 
return to near normal. If the weight and intake reductions 
of the LHA syndrome were to depend solely on a reduction 
of vagal tone, then one would anticipate that the maximal 
effects on intake and weight which could result from LHA 
lesions would be equal to those generated by vagotomy. 
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2.4 Experiment 3: LHA-Sympathectomy 
The failure of vagotomy to reverse the LHA syndrome 
in spite of the reciprocal effects of LHA and VMH stimula-
tion of visceral function requires a ree,valuation of the 
nature of the change induced by LHA lesions. Explicit in 
the classic notion of hypothalamic control of food intake 
has been the idea that the VMH functions by inhibiting LHA 
activity. The amelioration of the VMII syndrome by vagotomy 
(i.e., cutting of the parasympathetic output which has close 
anatomical identification with the LHA) further reinforces 
this supposition. 
There would then seem two possibilities to account 
for the LHA effects. LHA lesions, unlike VMH lesions and in 
spite of the reciprocal effects of LHA and VMH stimulation, 
may not depend on modulation of visceral activity for their 
effect. The second alternative assumes, as the basis of the 
LHA effect, that the parasympathetic LHA inhibits the sym-
pathetic VMH; in other words, there may be a symmetrical 
hypothalamic system whereby the VMH effect owes its exis-
tence to an ascendancy (i.e., disinhibition) of parasym-
pathetic innervation of the viscera and the LIIA to an over -
balance in the direction of sympathetic innervation. 
Consistent with the second hypothesis, Opsahl [1973] 
showed a mild amelioration of the LIIA weight effect with 
adrenal demedullation. The results took the form of a 
35 
slight decrease in weight in the control animals which did 
not occur in the LHA group. 
The anatomy of the sympathetic innervation of the 
viscera is not, however, as clearcut as in the case of the 
parasympathetic system which houses its efferent, and 
afferent, pathways in a single pair of vagal nerve trunks. 
Besides the adrenal medulla, recent results would seem to 
suggest that direct symp·athetic nervous connections are 
capable of modulating visceral activity, and, in particular, 
endocrine pancreatic secretion [Miller, 1975]. If the LHA 
has its effect on intake and weight in a manner parallel to 
that of the VMH it may be via these connections. The 
following experiment examines the effect of destruction of 
the direct, nervous, sympathetic innervation of the viscera 
on the LHA syndrome. 
Of the techniques available for sympathectomy, sur-
gery is difficult on this rather diffuse system, and chemi-
cal destruction by either nerve growth inhibitory factor 
(immunosympathectomy, [see Levi-Montalcini and Angele tti, 
1966]) or 6-hydroxydopamine [Angeletti and Levi-Montalcini, 
1970] affects central and peripheral nervous tissue and 
requires that treatment be carried out in neonates in order 
to induce permanent destruction. Any later failure to 
observe an LH lesion weight reduction could then be as much 
a result of ineffective lesions as of a positive sympathec-
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tomy effect. Fortunately, a third chemical method of 
producing SNS destruction has recently been demonstrated. 
Guanethidine sulphate has been reported to produce wide-
spread, essentially complete destruction (greater than 98%. 
at the level of the cervical ganglion, according to Burn-
stock, Evans, Gannon, Heath and James, [1971]) of the SNS. 
It has the additional advantages of being effective in 
adult animals and of not crossing the blood-brain barrier 
and thus, when injected peripherally, of having no central 
effects. 
The following experiment was therefore designed to 
examine the effect of peripheral sympathectomy induced by 
guanethidine sulphate (GS) on the food intake, water intake 
and weight gain of male rats with, and without, lateral 
hypothalamic lesions. In addition, since no data appeared 
available on the effects of peripheral sympathectomy on 
intake and weight gain in normal, adult animals, an approp-
riate control group was added to allow this comparison. 
2.4.1 Method 
Subjects were, as in the previous experiment, adult, 
male Wistar-derived rats from the breeding colony of the 
John Curtin School of Medical Research (Canberra, Australia). 
Animals were randomly assigned into 4 groups. One group 
(LHA-GS; n = 9) received LHA lesions followed 4 weeks later 
by initiation of GS (Ismelin, kindly supplied by CIBA-GEIGY) 
treatment daily (25 mg/kg i.p.) for 6 weeks. A second 
group (LHA-Sham; n = 9) received LHA lesions followed by 
injections of physiological sa line. One group of control 
animals (Sham-GS; n = 9) received sham lesions followed 
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by GS. A second control group (Sham-Sham; n = 9) received 
sham lesions followed by saline. 
Food and water intakes we re measured in 24-hour 
periods before and 2 and 4 weeks following LHA or sham 
lesions, bi-weekly during GS or saline treatment, and weekly 
for 6 weeks following sympathectomy. Weigh t was measured 
on the day before LHA or sham lesion, daily until weight 
gain was seen following the lesions and recorded weekly 
thereafter. 
The lesion, and sham lesion, technique was as des-
cribed in Experiment 1 with coordinates and parameters and 
maintenance following the lesions as 1n Experiment 2 . 
Statistical analysis was done using a one-way, fixed 
effects analysis of variance at useful time points followed, 
where appropriate, by Schefff individual comparisons . 
2.4.2 Results 
The data are summarized in Figures 3 , 4 , and 5 
(see Appendix C for the F ra tio s). Mean body weight , food 
intake and wa ter intake of both LHA-lesioned groups remained 
significantly (p < .01 in all cases) below that of their 
appropriate control groups from the time of the first 
measurement following the lesion through the duration of the 
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Figure 3. The effect of guanethicljne sulphate 
sympathectomy on the mean food ond 1vater into_kes 
of groups of LHA lesioned ( ---o ---) and sham 
lesioned (--- • ---) m~Jc rats. LIi/\ lesioned-
s a 1 i n e in j e c t e d ( ---O ---- ) and s h ~1 rn 1 e s i o n e d -
s a 1 in e in j e c t e d ( -- • -- ) group s n r c inc 1 u de d for 
comparison. The dotted line und er the abscissa 
indicates the 6 weeks of injection of either 
guanethidine or saline. 
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Figure 4. The effect of guanethidine sulphate 
sympathectomy on the mean body weights of groups 
of LHA lesioned (- - -o- - -) and sham lesioned 
( - - -• - - - ) ma 1 e r at s . LI-IA 1 e s i one d - s a 1 i n e in -
j ected (--o--) and sham lesioned-saline in-
jected (--•--) groups are included for compari-
son. The dotted line under the abscissa in-
dicates the 6 weeks of injection of either 
guanethidine or saline. 
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Figure 5. Body weights of Figure 4 with the 
LHA lesioned groups expressed as a percentage 
of their appropriate controls . 
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experiment. Thus the maJor finding is the failure of sym-
pathectomy to reverse either the lower weight levels 
(Figures 4 and 5) or hypophagia and hypodipsia which result 
from electrolytic lesions of the LHA. This is perhaps most 
clearly seen in Figure 5 where the weights of the 2 LHA 
groups are expressed as percentages of the weights of 
their appropriate controls. It should be furt her noted from 
this figure that the mean weight of the LHA-lesioned, 
saline-injected groups remained at remarkably stable, al-
though reduced, level compared to its sham-lesioned control 
group [Powley and Keesey, 1970]. 
The second major result is the effect of GS sympa-
thectomy on weight and intake in normal, male rats. Both 
food and water intakes were significantly depressed by the 
second week of treatment (p < .01) as was weight (p < .01). 
The intake measures then rebounded to control levels (sig-
nificantly above control values, p < .0 5, only for water 
intake in the first week following GS tr eatment) . Weight 
remained below control values until th e fif th week following 
treatment (p < .05) but was not different over the fina l 
two weeks of the experiment (p < .05 and p < .10, respec-
tively). It seems probable from these results that peri-
pheral sympathectomy in adult animals has little permanent 
effect on level of regulated weight. Whether more subtle 
feeding effects occur is a matter for further experimenta-
45 
tion. 
2.4.3 Discussion 
The result of this and the previous experiment sug-
gest that whatever the nature of the change following LHA 
destruction, which is reflected in a level of weight sig-
nificantly below that of control animals, the change does 
not depend on either direct neuronal input from, or output 
to, the autonomic nervous system. Thus the LHA syndrome 
is not a perfect reciprocal of that condition observed 
following VMH destru·ction. 
There is the possibility of a complex interaction 
between the normally short-duration actions of the direct 
nervous sympathetic innervation of the relevant visceral 
organs and the longer term results of adrenal medulla 
activation. Alternatively, some recovery of function fol-
lowing destruction of one or the other segments of this 
complex system may be possible, presumably due to a com-
bination of hypertrophy in the remainin g part of the system 
and a post-denervation, post-synaptic hypersensitivity 
[Evans, Iwayama and Burnstock, 1973]. At present too 
little of these mechanisms is known to c omment meanin gfull y 
on these possibilities. 
CHAPTER THREE 
VMH INSULIN-GLUCORECEPTORS 
3.1 Introduction 
The major result of Chapter Two was the reversal by 
vagotomy of both the hyperinsulinemia and increased weight 
resultant upon electroJytic lesions of the VMH. While 
this finding certainly does not constitute proof, it is 
consistent with the notion that VMH hyperphagia and obesity 
are the result of a primary oversecretion of insulin. Thus 
we have the following two sets of overlapping results. 
First, electrical stimulation of the VMH yields hyper-
glycemia and a suppression of insulin secretion [Frohman 
and Bernardis, 1971; Miller, 197 SJ. VMH lesions lead to 
hyperinsulinemia [Hales and Kennedy, 1964] which seems 
dependent upon increased vagal activity [Experiment l; 
Frohman, Ezdenli and Javid, 1967; Kaneta, Kosaka and Nakao, 
1967]. Secondly, glucose infused i.v. or applied locally 
effects an increase in the firing rate of certain VMH 
neurons while insulin results in a decrease [Anand, 
Chhina, Sharma, Dua and Singh, 1964; Oomura, Ono, Ooyama 
and Wayner, 1969; Oomura, 1973]. Both sets of results are 
consistent with the notion of a primary role for the VMH in 
glucoregulation. The critical missing result is the one 
linking the two sets of data. That is, changes in the 
46 
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levels of VMH insulin or glucose have been shown to effect 
changes in VMH activity and changes in VMH activity have 
been shown to result in alterations in glucose and insulin 
secretion. However, the VMH activity changes induced by 
insulin or glucose have not been shown to hav e direct 
glucoregulatory effects. The experiments described in the 
following chapter focus upon this point. 
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3.2 Experiment 4: VMH Insulin Injections 
Numerous studies have established the existence of 
CNS insulin-sensitive receptors whose outputs are involved 
in peripheral regulation of glucose [Anderson and Hazel-
wood, 1969; Chowers, Lavy and Helpern, 1961; Szabo and 
Szabo, 1972; 1974; Woods, Chen and Porte, 1974]. Insulin, 
in these studies, has either been injected into the cerebral 
ventri~ular system or, in the cases of Szabo and Szabo [1972; 
1974), into the carotid artery. Hypoglycemia consistently 
results from both methods but using these procedures the 
dynamics and location of insulin receptor sites cannot be 
established. The ventromedial nucJei of the hypothalamus, 
however, offer a most likely locus. Insulin itself is known 
to effect a decrease in activity of spontaneously dis-
charging VMH neurons [Anand, Chhina, Sharma, Dua and Singh, 
1964; Oomura, Ono, Ooyama and Wayner, 1969; see also 
Oomura, 1973]. While insulin generally is not thought to 
facilitate glucose uptake in the brain [Crone, 1965], the 
VMH appears to be an exception [Debons Krimsky, Likuski, 
From and Cloutier, 1968; Smith, 1972]. The VMH is part of 
the sympathetic nervous system [Ban, 1964; 1966] and 
electrical stimulation results both in an increase of 
plasma glucose and a suppression of insulin release which 
would otherwise normally accompany the rise in systemic 
glucose levels [Frohman and Bernardis, 1971]. The 
following experiments were designed as an attempt to lo-
calize the brain area and outflow pathways of the central 
insulin receptors. 
3.2.1 Method 
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Experiments were performed on male, Wistar-derived 
rats of 300 to 350 grams, obtained from the John Curtis 
School of Medical Research (Canberra, Australia). They were 
4 hour fasted. Anesthesia was induced with sodium pento-
barbital (SO mg/kg i.p.), and the animal was placed in a 
stereotaxic unit. A microsyringe was mounted directly on 
the stereotaxic electrode carrier and the microsyringe 
needle (o.d. 0.40 mm) was used for the direct, unilateral 
injection into the brain. Only one injection was made per 
animal. The needle was positioned 1 mm above the 1nJec-
tion sites 5 minutes before injection. The first blood 
sample was then taken, the needle lowered into position, 
1 microlitre of either insulin (40 milliunits - crystal-
line zinc insulin) or denatured insulin injected over 30 
seconds, and the needle removed one minute later. The 
original blood sample and samples at 5, 10, 20, 30 and 
60 minutes post-injection were taken from the cut end of 
the warmed tail and assayed for glucose by the ortho-tolu-
idine method [Hyvarinen and Nikkila, 1962]. In these and 
all subsequent glucose assays the blood was taken directly 
into small tubes into which 2 to 3 drops of 4 % sodium 
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fluoride and 4% potassium oxalate had previously been placed 
and allowed to dry. In all normal animals of the following 
four experiments the initial pre-injection range of blood 
glucose was 95-107 mg% and all post-injection values are 
expressed as either an increase or a decrease relative to 
each animal's own initial value. Following the last sample 
the animal was killed with ether and the brain removed and 
hardened in 10% formalin. Sections were cut at 30 microns 
and every second section through the injection site stained 
with thionin. 
3.2.2 Results 
In this initial experiment insulin injections were 
made into the VMH, LHA and cortex. 
Figure 6 shows the injection sites. Insulin was in-
jected in.to 8 sites in the VMH, 5 in th e LHA, and 4 in the 
cortex. Denatured insulin was injected into 4 VMH loca-
tions. Figure 7 shows the changes in blood glucose. One-
way, fixed effects analyses of variance showed a significant 
effect of injection area at 5, 10 and 20 minutes following 
insulin injection (F ratios are gJven 1n Appendix D) . 
Scheff€ comparisons revealed a signiricant drop in blood 
glucose following insulin injection into the VMf-I (compared 
to denatured insulin) a t 5 (p < .01), 10 (p < .01 ), and 20 
(p < .05) minutes. No other individual comparisons were 
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Figure 6. Sections redrawn from the brain atlas 
of Pellegrino and Cushman [196 7]. Numbers near 
the top of the sections denote the anterior-
posterior coordinates of the sections in relation 
to the interaural line. Open circles indicate 
insulin injection sites where the blood glucose 
had changed less than 5 mg% by the 5 minute sample; 
half-filled circles indicate a drop of 5-10 mg%; 
and filled circles a drop of greater than 10 mg% . 
Open squares show injections of denatured insulin 
none of which produced a change larger than 3 mg %. 
Two extra sites are shown but not included in the 
analysis, one in the AHA and one ventra-1 to the 
VMII. 
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Figure 7. Changes in blood glucose in the hour 
following injection of insulin into the VMH (n = 8) , 
LHA (n = 5), or cortex (n = 4) and denatured in-
sulin into the VMH (Control; n = 4). Standard 
deviations are given by the number above or below 
the data points. Double asterisks indicate signi-
ficant difference between VMH and Control groups at 
the 0.01 level and the single asterisk at the 0 . 05 
level. 
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significant. The decrease following injection of insulin 
into the LHA was largely due to two rats with placements 
55 
on the medial border of the LHA whose blood glucose had 
dropped 8 and 9 mg% by the 10 minute sample. The 14.6 mg % 
mean VMH group blood glucose decrease observed in the 
present experiment using only a unilateral injection com-
pares favourably with the 27-28 mg % drop found by Szabo and 
Szabo [1972] with total perfusion of insulin induced via 
the carotid artery. 
3.2.3 Discussion 
The results .offer support for the localization of 
CNS insulin receptors within the VMH. The hypoglycemia 
found in the present study is consistent with the notion 
that insulin uptake in the VMH results in a reduction in 
electrical activity of certain specialized cells [Anand, 
Chhina, Sharma, Dua and Singh, 1964; Oomura, Ono, Ooyama 
and Wayner, 1969] and, further, is the first evidence that 
this activity has direct relevance to peripheral gluco-
regulatory mechanisms. The following experiments are 
designed to clarify the present result. 
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3.3 Experiment 5: Ventricular Insulin Injections 
Most of the studies which have demonstrated the hypo-
glycemic effect of centrally applied insulin have used in-
jections of insulin into the cerebral ventricular system 
[Anderson and Hazelwood, 1969; Chowers, Lavy and Helpern, 
1961; Woods, Chen and Porte, 1974]. The VMH lies in close 
proximity to the third ventricle. Hence, the hypoglycemia 
observed in Experiment . 4 may have been due to spread of 
insulin into this ventricle. This possibility was explored 
in the following experiment. 
3.3.l Method and Results 
Subjects and methods were as in the previous experi-
ment with the following alterations. A larger, elliptical 
hole was created in the skull on the midline and the sagit-
tal sinus was partially exposed. The microsyringe was 
tilted just off vertical and entered the brain along side 
the sinus. The needle was then lowered to within 3 mm of 
the injection site. The first blood sample was then taken 
and the remainder of the procedure was identical to that 
of the preceeding experiment. 
The results of injection of insulin into the third 
ventricle of 4 animals are shown in Figure 8. The VMH and 
control groups of Experiment 4 are shown for comparison and 
used for the statistical comparisons by one-way, fixed 
effects analysis of variance (see Appendix E for the F 
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Figure 8. Changes in blood glucose in the hour 
following injection of insulin into the third 
ventricle (n = 4). The VMH-insulin and VMH-
denatured insulin groups of Experiment 4 are 
included for comparison. Injection of insulin 
into the ventricle caused a si gnificant depression 
(p < .05) in blood glucose only at 20 minutes 
following injection. 
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ratios) followed by Scheffe comparisons. Ventricular in-
jection of insulin caused a decrease in blood glucose which 
approached statistical reliability at 10 minutes following 
injection (p < .10) and was significant at 20 minutes 
(p < .05). The ventricular group differed from the VMH 
group at 5 minutes (p < .0 1) and at 10 minutes (p < .05) 
post-injection. 
3.3.2 Discussion 
Diffusion of insulin into the third ventricle cannot 
account for the initial large drop in blood glucose seen 
following VMH insulin injections. 
bute to the length of the effect. 
It may, however, contri-
Conversely, the delayed 
hypoglycemia in the present experiment may reflect diffu-
sion from ventricle to VMH. It is not possible, at the 
present time, to say whether the hypoglycemia of both ven-
tricular and VMH groups 20 minutes following the insulin 
injection reflects an effect on the same mechanism. 
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3.4 Experiment 6: VMH Insulin in Diabetics 
The emphasis thus far has been on the role of the VMH 
in glucoregulation via its control of insulin secretion. 
Glucoregulation, however, seems most reasonably viewed as 
integrated patterns of visceral activity initiated to 
facilitate either increased availability or increased dis-
posal of glucose. The diabetic animal presents a prepara-
tion with exaggerated rates of both hepatic glucose output 
and free fatty acid efflux but only very limited capacity 
to alter insulin secretion in the face of a glucoregulatory 
challenge. If mechanisms other than altered insulin contri-
bute to the hypoglycemia following insulin injections into 
the VMH, then they may be sufficiently visible to result in 
hypoglycemia following VMH insulin in the diabetic rat. 
3.4.1 Method and Results 
Subjects were male rates of the same age and origin 
as those of Experiment 4. Diabetes was induced with a 
single i.p. injection of streptozotocin (60-65 mg/kg in 
citrate buffer pH 4.5) at least 3 weeks before the experi-
ment. Pilot work had shown severely diabetic rats (blood 
glucose >350 mg%) react badly to the stress o[ anesthesia 
and blood loss. Animals were therefor e screened for 
degree of diabetes 1 week before the present experiment. 
After a 6 hour fast they were lightly anesthetized with 
ether and a blood sample obtained from the tail. Blood 
glucose was analyzed and animals whose blood glucose levels 
were between 250 and 350 mg% were retained for use in the 
present experiment. All other procedures were as in 
Experiment 4. 
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Results are shown in Figure 9. Since anesthetic and 
blood sampling tended to reduce th e blood glucose of 
diabetics a certain amount over time, the 2 lines represent 
blood glucose changes of the diab e ti c animals of the present 
experiment and the VMH animals of Experiment 4 (for compari-
son), both corrected for appropriate control group changes 
(the blood glucose of each exper imen t al animal was adjusted 
for the mean change in its control group a t each time 
point). Four diabetic animals were found to have injection 
sites within the VMH. Their blood glucose drop (adjusted 
relative to 3 denatured-insulin diabetic controls) was 
significantly larger at 5 minut es compared to the VMII group 
(t = 2.74; p < .05 for a two - tail ed test) but tended to be 
less severe at 20 minutes (t = 1.83; p < .1 0 for a two-
tailed test). If this 20 minut e difference were found to 
be reliable with a larger group of animals , it might be 
interpreted as reflecting the contribution to the hypo-
glycemia of a slower pancreatic component. 
3 .4. 2 Discussion 
This experiment suggests that reduction in hepatic 
glucose output and/or decreased FFA efflux are significant 
contributors to the initial, marked hypoglycemia which 
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Figure 9. Changes in blood glucose in the hour 
following injection of insulin into the VMH of 
streptozotocin diabetic rats (n = 4). The VMH-
insulin group of Experiment 4 is included for 
comparison. The blood glucose drop of both 
groups is corrected f or changes in their approp-
riate V}1H - denatured insulin controls. The 
diabetic group displayed a greater hypoglycemia 
at 5 minutes following injection (p < .05). 
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results from insulin injection into the VMH. This is con-
sistent with the notion that it is an integrated series of 
metabolic events which accomplish the centrally-generated 
command for glucose output or, in this case, disposal. 
3.5 Experiment 7: VMH Insulin following Vagotomy or 
Sympathectomy 
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The speed of the initial hypoglycemia following 
insulin application to the VMH suggests a neural, rather 
than hormonal, mechanism. Both sympathetic and parasym-
pathetic nerves have been shown capable of modifying both 
hepatic glucose and pancreatic insulin secretion. Szabo 
and Szabo [1974] have already observed a partial reduction, 
following vagotomy, in the magnitude of the hypoglycemia 
attendant upon perfusion of the brain with insulin. Ad-
renergic alpha and beta block with phentolamine and 
propanolol, respectively, had no effect. 
The following experiment looked at the effect on 
blood glucose of direct application of insulin to the VMH 
in vagotomized animals. In addition, the data of a single 
sympathectomized animal are presented. 
3 . 5.1 1ethod and Results 
Vagotomy was performed as in Experiment 1 and ap-
proximately 1 month was allowed for recovery. The vagot-
omozed animals were then at the age of the animals of 
Experiment 4 but weighed slightly less. The insulin injec-
tion procedure was identical to that described for Experi-
ment 4 with the following exceptions: (1) no 60-minute 
sample was taken, (2) after the 30-minute sample the skull 
incision was sewn up and the animal was allo,~ed to recover, 
66 
and (3) access to water, but not food, was allowed for the 
next 24 hours. An acid secretion test for completeness of 
vagotomy was then carried out as described in Experiment 2. 
The brain was removed and the injection site 
localized as in Experiment 4. Five animals met the dual 
criteria of an insulin injection site within the VMH and 
complete bilateral vagotomy. Three vagotomized, denatured-
insulin-injected animals served as controls. Only 2 sym-
pathectomized animals were available and one had an ac-
curate VMH insulin placement. The results, shown in 
Figure 10, are equivocal. Because of the rather large 
variability, mean glucose changes, corrected for control, 
are plotted for the vagotomized group and the range, at 
each time point, of individual blood glucose values is shown. 
The blood glucose drop in the vagotomy group is not sig-
nificantly smaller than that of the VMH-insulin normals of 
Experiment 4 (t = 1.18; p > .20 for a two-tailed test). 
The single. sympathectomized animal did not appear to react 
differently from a normal animal. 
3.5.2 Discussion 
The results support the view thnt the vagus plays a 
substantial role in the hypoglycemia which results from 
central application of insulin. The distressingly large 
variability in both the present data and those of Szabo and 
Szabo [1974] may again be due to the use of acid secretion 
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Figure 10. Means and corresponding ranges of 
variation in the 30-minute period following 
injection of insulin into the VMB of a group 
of vagotomized animals (n = 5) and a single 
guanethidine-sympathectomized animal. The VMH-
insulin group of Experiment 4 is included for 
comparison. 
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in response to hypoglycemia as the test for completeness of 
vagotomy. It is almost certain that the fibers subtending 
this test function are not the ones involved in the present 
phenomenon and, at present, there is no reason to believe 
that the severing of one set of fibers subtending a par-
ticular function would have equal probability of destroying 
vagal fibers involved in any other function. 
A second criticism of the present experiment is that 
the anatomical locus of the phenomenon described in 
Experiment 4 is poorly defined and, as a result, the effect 
of any further manipulations, such as vagotomy, cannot be 
properly assessed. The primary objective of this chapter 
was to provide a link between studies showing alterations in 
VMH activity resulting from insulin-glucose changes, and 
studies showing visceral glucoregulatory shifts with 
electrically-induced VMH activity changes. As such, the 
results provide this important link. The technique em-
ployed represents the best of those readily available. 
However, given the results of Experiments 4, 5 and 6, there 
is still certainly the possibility that even if the 
phenomenon represents an integrated pattern of effects, 
anatomically distinct subsystems may stibtend various aspects. 
Thus a reasonable mapping study would necessitate, at very 
least, insulin injections or glucose injections in separate 
groups of animals with controlled hepatic glucose output, 
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pancreatic alpha and beta output, or free fatty acid 
efflux. Such a study, given the tedious glucose assay 
available, was beyond the scope of this thesis. It may be 
also argued that direct application of insulin (or any drug) 
could provoke entirely abnormal tissue reaction. Thus, 
having demonstrated the phenomenon with one technique, 
employing a combination of other techniques, such as that 
of Szabo and Szabo [1972; 1974] and of knife cuts of 
specific pathways (the more likely ones could be severed 
without serious interruption of blood supply to critical 
areas), may be best to provide further confirmatory data. 
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3.6 Model of VMH Function and Discussion of the Model 
The results presented in this chapter provide the 
necessary link between the studies showing that manipula-
tions of hypothalamic activity have marked effects on blood 
glucodynamics and those showing that insulin and glucose 
have substantial effects on the firing patterns of certain 
hypothalamic neurons. If these data provide the basis for 
hypothesizing a central VMH role in glucoregulation, then 
there is need for a model which can explain the dynamics 
of this glucoregulatory system. An attempt to provide such 
a model is presented below. In overview, an insulin-
glucoreceptor system is first devised to describe a group 
of VMH neurons, and the electrical activity of these cells 
is discussed in terms of their glucoregulatory effects. It 
is postulated that the VMH normally acts to stabilize 
glucose supply and that an oversecretion of insulin in 
reaction to the ingestion of food can account for the hyper-
phagia and weight gain resultant upon VMH lesions. Finally, 
the role of the VMH in long-term weight regulation and the 
effects of palatability on the final weight achieved are 
discussed in light of the model. 
The following receptor system is then generated as a 
model of certain neurons within the VMH area whose ac-
tivities are directly relevant to glucoregulation. It lS 
given first, not because these particular neurons are 
necessary to the conclusions reached, but because the 
receptor model does describe the existing data parsi-
moniously and will help in understanding how the proposed 
model of VMH functioning might work. 
The following 4 rules are seen to describe the 
activity of these specialized cells: 
(1) Insulin must be present at the receptor sites 
order for them to be responsive to glucose. This 
proposal relies on the studies showing destruction 
of the VMH following goldthioglucose to depend 
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. in 
on the presence of insulin [Debons, Krimski, Likuski, 
Cloutier and From, 1968; Smith, 1972]. 
(2) Activity in receptor sites not occupied by in-
sulin is spontaneously high, irrespective of glucose 
levels. 
(3) Glucose-free, insulin-occupi ed sites are 
quiescent. These latter 2 rules depend upon the 
studies of Anand, Chhina, Sharma, Dua and Singh [1964] 
and Oomura [1973] showing that an . . increase in 
circulating insulin levels or direct application of 
insulin reduces the electrical activity of certain 
V1H neurons. 
(4) Glucose reactivates the insulin-occupied sites 
[ nand, Chhina, Sharma, Dua and Singh, 1964; Oomura, 
1973]. 
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That is, empty or insulin-and-glucose-occupied sites 
are firing at maximal rate, but insulin-occupied sites are 
inactive. Figure 11 contains 3 examples of theoretical 
receptor activity graphs. 
The model is interesting in that it predicts mal-
adaptive reactions in the face of either no insulin or, at 
the opposite end of the scale, high or rising insulin levels 
in the absence of high blood glucose. Such reactions have 
been observed, however, under a number of circumstances. 
With low insulin, glucose levels are less effective 
at modulating the activity of the VMH which is at a high 
level. This should produce further increases in blood 
glucose while further suppressing insulin output [Frohman 
and Bernardis, 1971; Shimazu, Fukuda and Ban, 1966]. Such 
anomalous behavior is, in fact, observed. Following in-
jections of anti-insulin serum there is a prompt rise in 
blood glucose [Armin, Grant and Wright, 1960; Stern, Wagle, 
Sweeney and Ashmore, 1963] and in diabetes unrestrained 
hepatic glucose production is well documented [see Anderson, 
1974]. 
Rising central levels of insulin (without concomitant 
rise in blood glucose) should diminish VMH activity thereby 
reducing glucose production. This anomaly also has been 
observed [Storlien, Bellingham and Martin, 1975, based on 
Experiment 4; Szabo and Szabo, 1972] an<l is particularly 
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Figure 11. Three examples of theoretical changes 
in insulin-glucoreceptor activity of the VMH with 
changes in the plasma concentration of insulin 
and glucose. 
a: >- HIGH / 
HIGH 
// 0 I-
t- -a..> // w-CJ I-
W(.) // a: <( 
LOW LOW 
INCREASING GLUCOSE _.,. 
NORMAL INSULIN 
', 
', 
', 
' INCREASING INSULIN 
NORMAL GLUCOSE 
HIGH••-----
LOW 
• INCREASING GLUCOSE _,. 
NO INSULIN 
---.J 
U7 
76 
clear in the case of conditioned hypo glycem ia [see Woods 
and Kulkosky, 1976 for review] where exogenous (or stimu-
lated endogenous) insulin elicits not the adaptive response 
of increased glucose output to maintain normoglycemia, 
but, in fact, causes reduced glucose production. The data 
of Szabo and Szabo [1972] are in excellent accord with the 
post-hoc predictions of the model. They used a preparation 
whereby insulin could be infused into the carotid artery 
and anti-insulin serum into the jugular vein to avoid 
systemic effects. This results, in the normal animal, in a 
decrease in blood glucose. The effect is much greater 1n 
diabetics and is absent in hyperinsulinemic animals. Ac-
cording to the present model, in the diabetic glucose output 
is maximal and subject to ma xima l decrease. In hyperinsuli-
nemic animals, the effect would already be minimal and no 
change would result from further insulin. 
It is, of course, possible th at the VMH neurons 
affected by glucose and insulin are independent of the 
neurons of passage relevant to g lucoregulation, or in-
hibitory with respect to these same fibers. The reversal 
of the hyperinsulinemia o f the V1H syndrome by vagotomy 
(Experiment 1) and the induction of hypoglycemia by appli-
cation of insulin to the VMH [Storli en , Bellingham and 
Martin, 1975, based on Experiment 4) make these possibil-
ities unlikely. 
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The postulated VMH insulin-glucoreceptors are excita-
tory with respect to the glucoregulatory system , which 
passes through (or is generated in) the VMH area, and extend 
inhibitory collaterals to the LHA [Tannenbaum , Paxinos and 
Bindra, 1974]. This is represented graphical ly in Figure 
12. The model also includes provision for influences based 
on the sensory qualities of food [C ampbel l, Bindra, Krebs 
and Ferenchak, 1969] which would be of prime importance if 
the VMH is shown to play a central role in the gluco-
regulatory adjustments which anticipate a meal. 
In the normal animal there would appear to be three 
possible phases of insulin release. Phase I occurs com-
pletely in anticipation of the act of ingestion [Parra-
Covarrubias, Rivera-Rodrigue z and Almarez-Ugalde, 1972; 
Wiley and Leveille, 1970]. Phase II occurs during the act 
of ingestion and before the actual rise in blood nutrients 
[Strubb e and Steffens, 1976]. Thi s readily available in-
sulin pool may normally be released by the same brain 
mechanism that drives the first phase or may be under 
control of a gastric-originated peripheral vago-vagal reflex 
or a combination of both. Phase III of insulin release 
would appear to be an outcome of the actual rise in blood 
nutrients. As we shall see, however, the magnitude of its 
expression seems capable of modulation by cephalic input. 
There are data whi ch suggest the role of the VMH is 
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Figure 12. The theoretical relationship of 
the insulin-glucoreceptors of the VMH to the 
sympathetic and parasympathetic components 
of the autonomic nervous system. 
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to initiate Phase I of insulin secretion and suppress Phase 
III with an appropriate intensity based on previous ex-
perience with the nutrient ingested. The evidence for VMH 
involvement in Phase III comes from the data of Martin, 
Konijnendijk and Bouman [1974]. They pair-fed control and 
VMH-lesioned animals at 67% of normal intake. This reduces 
basal insulin levels in VMH-lesioned animals to normal. 
However, the insulin response to glibenclamide (a synthetic 
insulin-stimulating drug) in the normoinsulinemic VMH 
animals is significantly greater than in their comparable 
controls. Certainly there is ample physiological evidence 
that activation of the sympathetic nervous system can reduce 
the insulin response to infused glucose [ 1iller, 1975]. 
The evidence for VMH involvement in Phase I is more 
circumstantial. Wiley and Leveille [1970] have demonstrated 
that an increase in insulin level to the anticipation of 
feeding time forms part of the physiological change which 
allows an animal to adapt to a restricted feeding schedule 
(i.e., 2 hours/day feeding). Panksepp [1971] revealed the 
inability of VMH-lesioned animals to adapt to such a res-
trict ed feeding schedule, and the nature of their deficit 
may lie in a failure to initiate anticipatory insulin secre-
tion. Perhaps the best evidence comes from Steffens [1969]. 
He devised a permanent, indwelling cardiac catheter from 
which repeated blood samples could be taken and blood 
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glucose determined. After observing the normal pattern of 
both behavior and blood glucose surrounding a spontaneous 
meal he measured the effect on blood glucose of denying 
access to food at the moment it appeared an animal was about 
to begin a subsequent meal. In normal animals a steady 
decline in blood glucose occurred following the denied 
"meal", presumably due to anticipatory insulin release. No 
such decline was observed in VMH-lesioned animals similarly 
denied meals . 
It seems quite plausible, then, that the primary role 
of the VMH is to stabilize energy supply in two ways: 
firstly, by initiating insulin output and suppressing glucose 
(and most likely free fatty acid efflux) production in 
anticipation of the rise in blood nutrients which rapidly 
occur following food intake, and, secondly, by initiating 
glucose output and suppressing insulin in the reactive phase 
following food ingestion to avoid a hypoglycemic overshoot. 
It should be reemphasized at this point that gluco-
regulation is most realistically seen as changing patterns 
of integrated metabolic events whose total result is a 
shift towards increasing or decreasing blood glucose levels. 
Perhaps the preeminent glucoregulatory control is food in-
take. Whether the VMH acts directly to influence this 
aspect of glucoregulation is not presently clear. Data 
generated in the next chapter may provide some clues towards 
answering this question and it will be discussed 1n their 
light. 
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VMH hyperphagia and obesity are then seen to be the 
primary result of the failure to suppress the reactive phase 
of insulin secretion (proportionally, the major contributor 
to total insulin output) and to initiate glucose output 
following a meal. This would lead to an abnormally large 
diversion of incoming nutrients away from availability for 
short-term energy usage (i.e., hypoglycemia) and into long-
term body stores (i.e., fat deposition). The immediate 
result would be a dearth of immediate energy for ongoing 
activity. Consistent with this view is the prediction 
that the initial result of a VMH lesion would be a shorter 
meal-to-meal interval. However, as LeMagnen [1959] has so 
elegantly shown, given time to adapt, rats eat to anticipate 
an energy deficit. Thus the VMH-lesioned animal may learn 
to increase the size of its meal in order to avoid the rapid 
recurrence of an available-energy deficit. The increased 
meal size observed in, for example, the Thomas and Mayer 
[1968] study may then only reflect the amount of food neces-
sary both to exhaust the readily available insulin reserve 
and to provide a "residue" of nutrient capable of meeting 
energy requirements over a reasonable post-prandial period. 
Panksepp and co-workers, in a series of papers 
[Nance and Panksepp, 1975; Panksepp, 1971a; 1971b; 1974; 
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Panksepp and Nance, 1972], have strongly suggested a 
critical role for the VMH in long-term body weight regula-
tion. They base this conclusion largely on the observations 
that VMH-lesioned animals: (a) apparently fail to adapt to 
a restricted feeding schedule (i.e., 1 hour access to fo od 
per day,[see Panksepp, 1971]), (b) become obese on 
palatable diets [Corbit and Stellar, 1964], (c) fail to 
increase food intake as much as controls to injections of 
protamine zinc insulin, and show smaller reductions in food 
intake following cessation of treatment [Panksepp and 
Nance, 1972], and (d) attenuate the vigor of refeeding after 
deprivation in diabetic rats [Panksepp and Nance, 1972]. 
Taking these points in turn, the present model of VMH func-
tion suggests that the VMH is important in the initiation 
of the metabolic adjustments to the anticipation of food 
intake. As suggested, these pre-ingestive reflexes may 
become increasingly important in the restricted feeding 
situation (1 hour/day access to food) employed by Panksepp. 
The deficit in the VMH animal may be the inability to make 
such adjustments. It should also be noted that Panksepp 
[1971a] reduced the weight of his VMH animals only to the 
weight of controls. The unwillingness of VMH animals to 
overcome any interference with their food ingestion at high 
body weights is well known. The present argument suggests 
that the vicious circle of hypersecretion of insulin re-
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quiring more intake, which in turn results in further in-
sulin output, accounts for the observation of obesity 
without resorting to the postulate of a long-term body 
stores deficit. The data showing "deficits" following 
insulin injections are particularly weak. Against a back-
ground of already very high circulating insulin levels and 
undoubted obesity-induced insulin resistance one could 
hardly expect insulin injections (or the withdrawal of 
these injections) to result in similar intake adjustments 
to those observed in control animals. Finally, I would 
agree with Panksepp that the hyperphagia which results from 
induction of diabetes almost certainly reflects a long-term 
body stores deficit signal. However, the very fact that 
VMH lesions do not cause the death of diabetic animals due 
to inanition seems to argue against the notion that the VMH 
is critical to monitoring such a body stores signal. The 
reduct ion in re-£ eeding vigor f o I lowing deprivation in VMH 
lesioned diabetics may only reflect some amelioration of 
the diabetic syndrome due to VMH destruction [York and Bray, 
1972: Table 4]. 
In summary, there appears little evidence that the 
VMH is involved in long-term adjustments in feeding be-
havior. Indeed, there is now quite good evidence that the 
VMH-lesioned animal defends the lower end of his body weight 
continuum with a vigor at least comparable to that of normal 
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animals [Beatty, 1973; Ferguson and Keesey, 1975; Franklin 
and Herberg, 1974; Kent and Peters, 1973; Marks and Remley, 
1972; Peters, Sensenig and Reich, 1973; Porter and Allen, 
1972; Wampler, 1973]. The upper end asymptote of weight 
for any particular VMH-lesioned animal would appear to 
reflect the degree of over-secretion of insulin which may, 
in turn, quantitatively reflect the amount of destruction 
of the relevant glucoregulatory VMH neurons and/or, as 
obesity ensues, increasing insulin resistance and the 
capacity of the pancreatic beta cell to secrete. 
Why palatability should have such a profound effect on 
this upper limit is unclear. There are perhaps 3 potential 
explanations. 
First, it may be an artifact of the lesion technique. 
The early report of Graff and Stellar [1962] offered pre-
liminary evidence for a dissocation between weight gain and 
exaggerated response to the gustatory qualities of food. 
They concluded that "there are separate, but overlapping, 
neural mechanisms for hyperphagia and for finickiness." 
Their conclusion is, however, based on a very limited number 
of animals in post-hoc groupings. The anatomical distinc-
tion suggested by Graff and Stellar has, nonetheless, 
apparently found at least some support in recent unpublished 
work by Bevan [quoted in Hoebel, 1976]. 
Second, in each of the repeated observations that 
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palatability is a critical variable determining the magni-
tude, and even the existence of VMH hyperphagia and 
obesity [see, for examples: Brooks, Lockwood and Wiggins, 
1946; Corbit and Stellar, 1964; Ferguson and Keesey, 1975; 
Franklin and Herberg, 1974; Strubbe and Steffens, 1975; 
Teitelbaum, 1955], there exist potential confounds. 
Quinine, used almost exclusively as the negative taste 
adulteration, has recently been shown to affect directly in 
vitro secretion of insul_in [Henquin, Horemans, Nenquin, 
Verniers and Lambert, 1975], a particularly critical point 
if the present analysis of VMH functioning is correct. 
On the "positive" taste side, each alteration of palatability 
invariably also involves both a shift in caloric density 
and a probable shift in rate of ingestion and/or absorption. 
For example, the apparent increase in palatability of wet 
mash over powdered chow over chow pellets may merely reflect 
a decreasing rate of ingestion and absorption. Although 
such data are not yet available, the ultimate peak of blood 
glucose for a given meal size most likely depends on the 
rate of ingestion/absorption and the amount of insulin 
secreted depends on the glucose peak. Correspondingly, 
any manipulation which increases the glucose peak in the VMH 
animal will also increase dramatically the magnitude of the 
insulin hypersecretion. 
The third possibility is that palatability would 
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continue to have a marked effect on VMH obesity even if 
caloric density and texture were controlled. Interactions 
between palatability and weight maintenance levels have 
not, as far as I am aware, been fully explored even in the 
intact animal. Certainly the short-term ef·fect on consump-
tion has been demonstrated for quinine and, on the positive 
side, for adulterations of diet involving addition of 
glucose, sucrose or fat. These latter diets, however, 
also involve changes in caloric density. There is no con-
vincing evidence that adulteration with non-nutritional 
sweeteners (e.g., saccharin) have any short- or long-term 
effects on body weight maintenance level in spite of in-
creased palatability (as judged largely by subjective 
evaluation in human subjects [see Mook, 1974]). The case 
for initial metabolic alterations based on palatability 
is much stronger. Increasing salivation [Wooley and Wooley, 
1973], gastric secretion [Pavlov, 1902] and pancreatic 
exocrine secretion [Behrman and Kare, 1968] with increasing 
palatability (without ingestion) have all been demonstrated. 
This is not unreasonable, as in the natural setting bitter 
substances are often poisonous as well, and sweetness is 
likely to correlate with caloric density. If we can assume 
that the metabolic shifts in response to palatability 
changes would extend to insulin, then by the argument of 
the previous paragraph even a pure increase in palatability 
(without accompanying caloric density or texture changes) 
would create, in the VMH-lesioned animal, a condition 
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once again of massive overs ecretion of insulin with its 
obesity-generating consequences. In the intact animal the 
initial increase in insulin secretion would be smaller 
(because of VMH inhibition) and once the caloric conse-
quences were judged to be the same as the original, less 
palatable diet, insulin secretion would be suppressed to 
"normal". 
Finally, this analysis presumes two things. First, 
that the normal animal would react to the aversive conse-
quences of oversecretion of insulin to a novel, palatable 
diet not by overeating the next time the diet was presented, 
but by suppressing insulin appropriately. The fact that 
long-term weight gain is not generally seen on palatable 
diets would support this assumption. Second, it assumes the 
physical substrate for generating these metabolic altera-
tions exists and is outside the VMH. Burton, Mora and Rolls 
[1975] have recently reported preliminary evidence of cer-
tain cells in the LHA whose firing rates to the presenta-
tion of given visual or taste stimuli are dependent upon 
the nutritional status of the animal. Given that result, 
it seems reasonable that firing rates 1n these cells would 
also change appropriately if nutritional state were held 
constant and palatability were varied. Such cells could 
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easily function as the necessary physical substrate for 
generating metabolic adjustments to changes in palatability. 
CHAPTER FOUR 
DIABETIC HYPERPLAGIA AND ADRENALINE ANOREXIA 
4.1 Introduction 
Diabetic hyperphagia and adrenaline anorexia have 
been repeatedly seen as phenomena critical to the gluco-
static theory of feeding. The characteristics of these 
preparations, and/or the interpretation of them, offer 
potential problems for the model of VMH function proposed 
in the preceding chapter. This chapter is devoted to a 
reanalysis of: (a) diabetic hyperphagia, and (b) adrenaline 
anorexia. 
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4.2 Experiment 8: Diabetic Hyperphagia 
The hyperphagia which results from induction of 
chronic diabetes by sub-total pancreatectomy, alloxan, 
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or streptozotocin has been used as an argument against the 
role of blood glucose in satiety under normal feeding 
conditions. As initially seen , "satiety" was directly 
correlated with blood glucose level. Thus the diabetic 
presented a problem case where abnormally high levels of 
blood glucose coexisted with hyperphagia. Mayer [1955] 
brought his theory in line with this observation by assuming 
that glucose utilization was the appropriate correlate of 
"satiety". The lack of insulin would then impede the up-
take of glucose in the diabetic and little would be 
utilized in spite of the high circulating levels. With the 
confirmation of apparent insulin-facilitated glucose uptake 
in the VMH [Debons, Krimsky, Likuski, From and Cloutier, 
1968; Smith, 1972] the "glucostatic" theory was further 
refined to an approximation of its present form. 
Diabetic hyperphagia, however, again becomes some-
thing of a problem for the model proposed in the preceding 
chapter. In the normal animal high activity in the insulin-
glucorecep~or VMH neurons is principally generated by high 
glucose levels in the presence of "normal" insulin, an 
event correlated with meal offset. While that relation may 
be spurious, it is perhaps more reasonable to assume that 
92 
there is some force in · the direction of suppression of 
feeding associated with high levels of activity in those 
particular VMH neurons. The problem arises in the diabetic 
case where very high levels of receptor activity are 
generated for an entirely different reason, that of 
theoretically zero insulin (which eliminates any effect of 
the abnormally high blood glucose). However, despite their 
entirely different origins, there is no a priori reason to 
suggest that the high VMH insulin-glucoreceptor activity 
of the immediate post-prandial normal animal is seen as 
reflecting any different phenomenon from the high activity 
generated by the insulin-deficient diabetic. Thus a predic-
tion which may be rightly forced from the present position 
is that diabetes should be associated with a reduction in 
food intake. 
It has been repeatedly demonstrated that various 
techniques for producing acute onset of diabetes all result 
in an initial hypopha gia which is followed by a gradual 
increase in food intake over the two weeks following induc-
tion of diabetes. With one notable exception [Booth, 1972], 
the significance of this pattern appears to have been either 
ignored or tacitly attributed to the debilitating effects 
of the diabetes-inducing treatment [Brodsky, Nelson and 
Guest, 1952; Kumaresan and Turner, 1965; Mayer and Bates, 
1952]. 
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Malaise arising indir ec tly as a side effect of drugs 
has been ruled out by Brodsky, Nelson and Guest [1952] who 
maintained animals with insulin following induction of 
diabetes with alloxan. Offset of insulin therapy in these 
animals was also followed by a hypoph agic to normophagic 
period of four to five days before onset of hyperphagia. 
A similar pattern has been observed with the strep tozotocin 
diabetic (pilot experiment observations). Acu te forms of 
diabetes induced by either anti-insulin serum [Anderson, 
Kilbourn, Robinson and Wright, 1963] or mannoheptulose 
[Panksepp, Tonge and Oatley, 1972] are also associated with 
an immediate reduction in food intake reversible, in the 
latter study, by 2-deoxy-D-glucose. 
An alternative to the malaise exnlanation assumes L 
that animals initially eat less th an normal ei ther for the 
simple reason that their blood glucose levels are far above 
normal or because some correlate or offshoot of the high VMH 
insulin-glucoreceptor activity is rea<l as reflecting the 
immediate post-prandial state. 
The gradual onset of hyperphagia would then represent 
an over-ride arising fr om a long-term control system res-
ponsive to depletion of body tissue. If such an explanation 
is appropriate, then reducing body weight prior to induction 
of diabetes should result in a shorter period of post-
induction hypophagia and increasing body weight should 
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prolong this hypophagic period. The present experiment is 
designed to test this hypothesis by measuring the food in-
take of fat and thin rats following the onset of diabetes 
induced by streptozotocin. 
4.2.1 Method 
Subjects were female, Wistar - derived rats obt ained 
from the breeding colony of the John Curtin School of Medical 
Research (Canberra, Australia). All groups were equated for 
weight before treatment and individual animals ranged from 
180 to 220 gms. Two groups were starved until their weight 
had reached 90 % and 80 % of pre-starvation levels and then 
maintained at those percent age levels (relative to control) 
with appropriate amounts of food given daily at the beginning 
., 
of the dark period (1900 hours). Another group of animals 
received insulin injections of 8-12 U/kg daily until reaching 
110 % of control weight and were maintained at the 110 % level 
·with appropriate amounts of insulin . After 2 weeks at 
maintenance all animals were deprived of food at the begin-
ning of the light period (0700 hours) and injected at 1300 
hours with 65 mg/kg i.p. of streptozotocin (kindly supplied 
by Upjohn Corporation of Kalamazoo, Michiga11) in citrate 
buffer (pH 4.5). Control animals received an equivalent 
volume of buffer. Food and water were then continuously 
available for the remainder of the experiment and measured 
in 24-hour periods from 1900 hours starting the evening of 
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the injection. A weighed amount of pellets (Mecon Rat 
Chow) was placed 1n the cage and those remaining weighed 
again at the end of the 24-hour period. Spillage, col-
lected on paper towels placed und er the individual cages , 
was air dried. The spilled amount was subtrac t ed from the 
difference between the initial food weigh t a nd weight 
remaining at the end of the 24-hour period to give a final 
intake figure. On the sixteenth day post-injection, all 
animals were deprived for 6 hours, lightly anesthetized with 
ethe r and blood sampled from a tail vein for glucose 
analysis by the ortho-toluidine method [Hyvarinen and 
Nikkila, 1962]. Blood glucose of the diabetic animals 
ranged from 330 to 500 mg% and analysis of variance revea l ed 
no differences between diabetic groups . Controls ranged 
from 87 to 109 mg %. 
4. 2 .2 Results 
Figure 13 gives the food intake results in the 15 
days post-injection in terms of consumption per 24-hour 
period for the 4 diabetic groups, for normal controls . and 
for controls treated identically with the 80% group except 
for ac tual administration of the strepto zotocjn. Day by 
day, one-way analysis of varjance with fixed effects was 
done on the data displ ayed in Figure 13 (see Appendix F 
for a summary of the F ratios) followed by Scheffe indivi-
dual comparisons where appropriate. Differences at the 
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Figure 13. The effect of increased (110% group , 
n = 6), normal (100 % group, n = 8) or decreased 
(90% group, n = 9; 80 % group, n = 6) body weight 
on food intake over the 15 days following inJec-
tion of streptozotocin. Food intake of normal 
(100 %-C group, n = 8) and decreased (80%-C group, 
n = 5) body weight controls are included for 
comparison. 
*differs from normal controls, p < .01. 
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0.01 level were considered significant. 
In summary, when compared to controls, food intake 
in the 110% group was reduced for 4 days following inJec-
tion and increased by day 12; 100% group, reduced for 2 
days and increased by day 6; 90 % group, reduced no days and 
increased by day 3; and the 80 % group, reduced no days and 
increased by day 2. The latency to onset of hyperphagia 
is clearly a function of the pre-injection body weight. 
For example, the time to an arbitrary criterion of 25 gms 
food intake per 24 hours was 13.8 days for the 110 % group, 
9.4 for the 100 % group, 6.0 for the 90 % group and 3.8 days 
for the 80 % group. These differences occur in the absence 
of any differences in blood glucose (as measured on day 16) 
or differences in water intake among the 100 %, 90 % and 80 % 
groups. Water intake was reduced in the 110 % group for 1 
day and was elevated compared to controls by day 2 in all 
diabetic groups. 
In addition to 24-hour intakes, diurnal cycling data 
provide further evidence against the hypothesis that the 
initial hypophagia reflects a malaise. The ad libitum 
control animals consumed 16.8 ±1.7 % of their 24-hour intake 
during the light period (0700 - 1900 hours). On the second 
day after induction of diabetes the 100 % diabetic gr oup 
consumed 14.0 ±3 .1 % of their intake during the light period. 
It seems unlikely that an animal who was hypophagic because 
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it was ill would maintain such an accurate diurnal intake 
rhythm. By day 15, when the hyperphagia of the 100% 
diabetic group was at asymptote, the animals of that group 
were still consuming only some 28% of their food during 
the light period. 
4.2.3 Discussion 
The results argue strongly against the notion that 
the initial 4 to 5 day hypophagic to normophagic period 
following induction of diabetes reflects a debilitation of 
the animal. By the second day post-injection, diabetic 
animals of the 80 % group are already markedly hyperphagic 
relative to initially comparable control animals. The time 
of onset of hyperphagia is clearly a function of depletion 
of body tissue. 
An argument which can be made against the present 
results is that there is most likely a positive correlation 
between initial body weight and ketosis and, thus, by re-
ducing .body weight, ketotic malaise might be reduced. Three 
points are relevant to this argument. First, tests for 
urine · ketones by Ames Lab-Stix on the second and third days 
post-streptozotocin registered only+ or++ for the 100 % 
diabetic group (on a scale of Oto+++), a relatively mild 
ketosis. Second, as pointed out, hypophagia due to illness 
and accurate diurnal fluctuations in food intake seem to be 
an unlikely combination. Finally, there are no data which 
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demonstrate that mildly elevated ketone levels would result 
in a reduction in food intake. Indeed, there is reason to 
believe that such elevations might increase food intake. 
The very survival of an animal made diabetic by, for example, 
alloxan would appear to depend on the animal's ability to 
overeat [Brodsky, Nelson and Guest, 1952]. 
The hyperglycemia and depleted pancreatic insulin of 
the streptozotocin diabetic syndrome is fully developed, 
and stable, by 24 hours post-injection [Junod, Lambert, Orci, 
Pictet, Gonet and Renold, 1967]. Thus, the effects of a 
carbohydrate-based satiety system should be stabilized from 
24 hours to 2 weeks post-injection. Any change in food 
. in-
take may then be reflecting a relatively pure change in the 
power of signals generated in the long-term system. Al-
thou gh the nature of this system is in dispute, the present 
syndrome may offer an excellent experimental model with 
which to study long-term energy control unencumbered by 
fluctuations in short-term signals. 
Finally, Le Magnen, Devos, Gaudilliere, Louis-
Sylvestre and Tallon [1973] have suggested the neuro-
endocrine basis for diurnal intake rhythm may be a greater 
insulinosecretory responsiven ess to hyperglycemia at night 
compared to responsiveness during the day. The existence 
of normal diurnal cycling in the diabetic animal whose 
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insulinosecretory capabilities are insufficient to control 
its blood glucose levels would seem to argue against Le 
Magnen's suggestion. 
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4.3 Experiment 9: Adrenaline Anorexia and Diabetes 
The anorexia which results from i.p. injections of 
adrenaline has been used as an argument against the tradi-
tional "glucostatic" theory on the basis of the following 
considerations. In order to produce anorexia via a 
"glucostatic" mechanism, adrenaline would either have to 
increase 6-glucose directly or do so indirectly by in-
creasing both insulin and glucose levels. Any indirect 
effect is likely to be marginal as adrenaline, while known 
to increase blood glucose, in addition, suppresses insulin. 
Its direct effect, at least peripherally, is to decrease, 
rather than increase, 6-glucose [Somo gyi , 1951]. It is 
questionable whether adrenaline crosses the blood-brain 
barrier [Weil-Malherbe, Axelrod and Tomchick, 1958]; how-
ever, even when applied centrally it causes an increase, 
rather than decrease, in food intake [Grossman , 1967]. 
Russek [1971; 1976] has synthesized a good deal of 
the literature on adrenaline anorexia within his own frame-
work of peripheral control of food intake. In essence, 
Russek suggests that the adrenaline anor exia observed de-
pends on the glycogenolytic effect of adrenaline (i . e ., 
rate of glucose transport across liver membrane). 
On the other hand, the interpretation from the in-
sulin-glucoreceptor argument proposed here would be that the 
hyperglycemia and suppression of insulin secretion following 
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adrenaline injection result in a high level of VMH activity 
(i.e., large number of empty and insulin-and-glucose-
occupied receptors) and that this high level of activity 
results both in a potentiation of the hyperglycemia and, 
either directly or indirectly, a cessation of feeding. 
Two demonstrations were then aimed at defending this 
viewpoint. The first attempted to demonstrate that the 
hyperglycemia was the relevant stimulus for food intake 
suppression following adrenaline. It was presumed that 
adrenaline-induced hypercglycemia would be absent in a 
diabetic ·but that if the anorexia were due to any other 
effects of adrenaline these would still be present. 
Secondly, since the diabetic is also deficient in liver 
glycogen, Experiment 9 does not differentiate between the 
present proposal and that of Russek. However, Russek's 
framework requires neural pathways from the liver to the 
brain. Two experiments looked at adrenaline anorexia in 
vagotomized (Experiment 10) and sympathectomized (Experi-
ment 11) rats. 
In this first experiment adrenaline anorexia was 
compared between normal and diabetic rats. 
4.3.1 Method 
Diabetes was induced by a single, i.p. injection of 
streptozotocin (65 mg/kg in citrate buffer of pH 4.5) at 
least 3 weeks before the beginning of the experiment. It 
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was initially intended to assess the anorexic effects of 
adrenaline on animals deprived of food for 24 hours. How-
ever pilot work revealed that diabetic animals, already 
lighter than controls, lost even more weight in absolute 
terms over the 24-hour fast (i.e., a much larger percentage 
of body ·weight). Three groups were eventually formed: 
(1) control animals (n = 9) 24-hour deprived, (2) diabetic 
animals (n = 9) 24-hour deprived, and (3) diabetic animals 
(n = 9) 11-hour deprived (a period that resulted in ap-
proximately the same percentage body weight loss as that 
seen over 24 hours deprivation in controls). All diabetic 
animals had blood glucose levels at least 280 mg %. 
Treatments were separated by 4 days and run as 
follows. All animals were deprived for their appropriate 
lengths of time on two occasions with no injection to ac-
climatize them to the deprivation procedure. Following the 
third, fourth and fifth deprivations, animals received 
either physiological saline (10 ml/kg i.p.), a low dose of 
adrenaline hydrochloride (0.12 mg/kg i.p. in a volume of 
10 ml/kg) or a high dose of adrenaline hydrochloride (0.18 
mg/kg in a volume of 10 ml/kg). Order of treatments was 
completely counterbalanced. Food (Mecon rat cubes) was made 
available immediately after injection and food intake was 
measured one-half hour, 1 hour and 2 hours later. Spillage 
was collected on paper toweling under the cages, air dried 
10S 
and corrected for when making intake calculations. A two-
way analysis of variance (3 x 3) was carried out treating 
the repeated measures on the Treatment factor (saline, 
adrenaline-low and adrenaline-high) as a random effect and 
the Groups factor (Control, Diabetic-24 and Diabetic-11 
as a fixed effect. Data for food intake af ter 1 hour and 
2 hours are also shown in Table 1. Scheffe individual 
comparisons were used for individual comparisons. 
4.3.2 Results 
The data are summarized in Table 1 (see Appendix G 
for F ratios). 
The results demonstrate that minimizing the changes 
in blood glucose and insulin minimizes the anorexic effects 
of adrenaline. 
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TABLE 1 
Food intake (gms) over the 2 hours following injection of 
either physiological saline or adrenaline hydrochloride 
(low dosage: 0.12 mg/kg; hi gh dosa ge : 0.18 mg/kg) in 
normal animals deprived 24 hours (Control) and d iabe tic 
animals deprived either 24 hours (Diabetic-24) or 11 hours 
(Diabetic-11). There were 9 animals in each group. 
GROUP TREATMENT FOOD INTAKE (gms) 
1/2 hour 1 hour 2 hours 
Control Saline 3.14 1.26 0.42 
Adrenaline-low 0.93 1.51 1.88 
Adrenaline-high 0.29 0.91 2.03 
Diabetic-24 Saline 2.62 2 .78 1.54 
Adrenaline-low 2.27* 2.4 1 1.89 
Adrenaline-high 2.12* 2.59 1.88 
Diabetic-11 Saline 2.41 1.93 1.07 
Adrenaline-low 2.00* 1.88 0.93 
Adrenaline-high 1.93* 1.69 1.54 
*indicates significant difference from appropriate Control 
condition (p < .05) on comparisons made using the one-half 
hour intake data. 
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4.4 Experiment 10: Adrenaline Anorexia and Vagotomy 
Russek [1971; 1976] has presumed the vagus to be the 
likely neural pathway carrying glycogen depletion signals 
from the liver to the brain. This would seem reasonable 
from the data of Niijima [1969] showing a good relationship 
between vagal firing rate and concentration of glucose per-
fusing the liver. The present experiment looked at the 
effect of chronic, bilateral subdiaphragmatic vagotomy on 
food consumption following adrenaline. 
4.4.1 Method and Results 
Vagotomy or sham vagotomy was performed as described 
in Experiment 1. At least 4 weeks were allowed between 
vagotomy and the beginning of the adrenaline injection phase 
of the experiment. 
The experiment was run according to the method of 
Experiment 9 with all animals deprived 24 hours at the onset 
of each treatment. Five deprivations (each separated by 
4 days) were instituted, the first 2 acclimatized animals 
to the procedure, and the following 3 preceded injection 
with either physiological saline, a low dose of adrenaline 
hydrochloride (0.12 mg/kg) or a hi gh dose of adrenaline 
hydrochloride (0.18 mg/kg). All solutions were given i.p. 
in a volume of 10 ml/kg. Counterbalancing of treatment 
order was incomplete in the vagotomy group due to elimina-
tion of a single animal on the basis of the acid secretion 
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in response to insulin test (see Experiment 2) carried out 
following the treatment phase of the experiment. A two-
way analysis of varjance with mixed effects of vagotomy and 
sham-vagotomy groups by treatment (2 x 3) was done on the 
one-half hour data. The data on which the analysis was 
based, as well as data regarding food intake after 1 and 2 
hours are shown in Table 2 (F ratios are contained in 
Appendix H). Stheff~ comparisons were carried out to 
determine which one-half hour intake differences were sig-
nificant. 
TABLE 2 
Food intake (gms) over the 2 hours following injection of 
either physiological saline or adrenaline hydrochloride (low 
dosage: 0.12 mg/kg; high dosage: 0.18 mg/kg) in 24-hour 
deprived sham-vagotomized (n = 6) or vagotomized (n = 8) 
animals. 
GROUP TREATMENT FOOD INTAKE (gms) 
1/2 hour 1 hour 2 hours 
Sham-vag. Saline 2.89 1.20 0.55 
Adrenaline-low 1.03* 1.33 1.90 
Adrenaline-high 0.34* 0.72 2.63 
Vagotomy Saline 3.41 0.96 0.41 
Adrenaline-low 1.46* 1.41 1.76 
Adrenaline-high 0.5 7* 1.09 2 .95 
*indicates significantly different (p < .05) from approp-
riate saline control on comparisons made using the one-
half hour intake data. 
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The anorexic effect of adrenaline was the same in 
both vagotomized and sham-vagotomized animals thus offering 
no support for Russek's hypothesis. While again the 
presently employed test for completeness of vagotomy may 
be questioned, it seems unlikely that destruction of the 
vagus sufficient to eliminate both hypoglycemic acid secre-
tion and any visual remnants of esophagal nervous tissue 
would be insufficient to affect significantly vagal fibers 
subtending a glycogen depletion signal. 
110 
4.5 Experiment 11: Adrenaline Anorexia and Sympathectomy 
The sympathetic nervous system is an alternative 
substrate which could mediate Russek's "glycogenostat". 
Because surgical interruption of this system is difficult 
in the rat, chemical destruction with guanethidine sulphate 
was employed. This, as previously pointed out, offers the 
advantages of essentially complete peripheral SNS destruc-
tion with no central effects. 
4.5.1 Method and Results 
Sympathectorny was performed as in Experiment 3 (6 
weeks of daily, i.p., 25 mg/kg injections of guanethidine 
sulphate) while the control group received the same number 
of injections of an equivalent volume of physiological 
saline. Approximately 1 month was allowed beyond cessation 
of treatment with GS before the experiment was initiated. 
The method of Experiment 9 was again followed. Five 24-hour 
deprivation periods were imposed, each separated from the 
other by 4 days. The last three deprivations each preceded 
injection with either physiological saline or one of two 
adrenaline hydrochloride dosages (low: 0.1 2 mg/kg ; hi gh: 
0.18 mg/kg) in a counterbalanced design. As in Experiment 
9 and 10, a two-way mixed effects analysis of variance was 
performed on the one-half hour intake data, followed by 
Scheff~ comparisons. 
Table 3 summarizes the data (Appendix J contains the 
F ratios). 
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TABLE 3 
Food intake (gms) over the 2 hours following injection of 
either physiological saline or adrenaline hydrochloride 
(low dosage: 0.12 mg/kg; high dosage: 0.18 mg/kg) 1n 
24-hour deprived sympathectomized (n = 6) or sham-
sympathectomized (n = 6) animals. 
GROUP TREATMENT FOOD INTAKE (gms) 
1/2 hour 1 hour 2 hours 
Sham- Saline 3.29 1.14 0.62 
sympathectomy Adrenaline-low 1.10* 1.48 2.00 
Adrenaline-high 0.22* 0.83 2.41 
Sympathectomy Saline 3.06 0.99 0.69 
Adrenaline-low 1.03* 1.66 2.13 
Adrenaline-high 0.41* 0.92 2.17 
* indicates significantly different (p < .05) from ap -
propriate saline controls on comparisons made using the 
one-half hour intake data. 
As with vagotomy, sympathectomy has no significant 
effect on the degree of anorexia induced by i.p. adrena line. 
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4.6 Discussion of Experiments 9, 10 and 11 
Taken together, the results of these three experi-
ments provide evidence favoring a central, rather than 
peripheral, basis for adrenaline anorexia and suggest the 
phenomenon relies on changes in blood glucose and insulin 
for its expression. 
However, while finding no support in the present 
results, Russek's arguments do focus on an important issue. 
Russek [1976] suggests a direct role in feeding for his 
peripheral "glycogenostat" but only an indirect role for the 
central glucoreceptors via their effects on blood glucose. 
Certainly this latter position is very much in sympathy with 
the analysis of VMH function made in this thesis. The data 
thus far available have not been directed towards deter-
mining whether the changes in food intake following manipula-
tion of . VIVIH activity are a direct result or indirectly come 
about from changes in glucoregulation. However, it seems 
reasonable to hypothesize that the VMH would have limited 
direct effect on feeding within a fairly broad, but normally 
occurring, range of insulin and glucose levels and of body 
energy reserves just as it is reasonable that an animal 
eats to anticipate deficits rather than as an emergency 
reaction to such depletion. As Fitzsimons [1972] concluded 
in his comprehensive review of thirst: "In normal circum-
stances drinking is largely anticipatory of future needs 
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for water . II . . . The same is probably true for hunger 
[Le Magnen, 1959; see also Oatley, 1973]. It does seem 
unreasonable that an animal would wait, following a meal, 
for the declining level of some metabolite signalling a 
deficit before initiating a fur ther meal (especially a 
metabolite as critical to brain function as glucose). 
At the extremes of the blood glucose range (in emer-
gency conditions), the VMH may play an increasingly large, 
and direct, role in feeding (even though its signals might 
be overridden by long-term influences as in the case of the 
diabetic). Thus while Russek pays less attention to dif-
ferentiation between normal and emergency conditions, I 
would suggest that the levels of hyperglycemia produced by 
the dosages of adrenaline normally used to induce anorexia 
would constitute an "emergency" for the animals and result 
in direct glucoregulatory depression of feeding . 
Mayer's "glucostatic" theory still receives much 
attention. If the present analysis is correct then it 
should be limited to those feeding responses generated 
. in 
emergency hypoglycemic or hyperglycemic states. In the 
normal, free-feeding animal the "glucostatic" metabolic 
patterns are probably just that , changes induced to 
stabilize blood glucose availability and are not likely to 
influence feeding directly. 
CHAPTER FIVE 
THE FEMALE ESTRUS CYCLE AS A MODEL FOR VMH OBESITY 
5.1 Introduction 
The thesis, to this point, has been directed at 
developing, and justifying empirically, a model of VMH 
function which sees the predominant role of that structure 
as one of maintaining stable glucose supply to the brain. 
In order to proceed with this analysis it is of obvious value 
to identify a preparation in which varying levels of ~1H 
activity lead to signific~nt shifts in energy balance and 
which is of a more physiological nature than the electrolytic 
lesions upon which so much of the theorizing about VMH 
function has been based. Electrolytic lesions are, at best, 
a crude disruption of normal neural functioning. This is 
particularly true in the case of a lesion of the VMH whose 
anatomical location places it in close proximity to numerous 
fiber tracts, especially those subserving a multitude of 
hormonal functions. In fact, so complicated is the VMH 
lesion preparation that of the thousands of studies employing 
the technique, not one has convincingly located that anat-
omical locus (in or around the ventromedial area) from which 
a maximal weight effect may be expected. 
Of the weight and food intake fluctuations which 
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naturally occur 1n animals, those accompanying the estrus 
cycle in female rats have been seen as phenomena in whose 
origin the VMH played a major role. The following chapter 
explores the possibility that the rhythmic energy balance 
fluctuations of the estrus cycle are driven by changes in 
VMH activity and hence that those fluctuations can be used 
to further the investigation of the VMH's role 1n energy 
balance. 
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5.2 Experiment 12: Estrus Cycle and Insulin 
The rhythmic changes in food intake and weight ac-
companying estrus cycling in female animals are well 
documented [see Wade, 197 2]. In intact animals , conditions 
of high estrogen (proestrus, estrus) are associated with 
low levels of food intake and weight loss while diestral, 
pregnant, or pseudopregnant animals (low es tro gen) have 
relatively high rates of weight gain. Food intake rises 
in ovariectomized females to stabilize weight at approxi-
mately 20 % higher levels than normal. Food intake then 
reduces to a level which sustains that weigh t [Tartellin 
and Gorski, 1971]. Single injections of es tro gen generally 
produce a decrease in food intake, although th ere is some 
controversy over a longer series of injections [see I ade, 
1972]. The mechanism of th e inhibitory effec t of estrogen 
on food intake and weight is, ho,ever, obscure. The pos-
sibility of a complex interaction of estrogen and other 
hormonal mechanisms (especially prolactin) or a direct 
effect of estrogen on isceral functioning certainly cannot, 
at present, be dismissed. Ho, ever a some~hat simpler system, 
in ol ing direct autonomic innervation of the viscera, has 
rece1 ed little attention. 
The similarities between o ariectomized and ~t1H-
lesioned female animals may provide an interesting clue to 
the estrogen effects on food intake and Keight. Following 
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both ovariectomy and VMH lesions the animal increases food 
intake in order, apparently, to increase her body weight 
to a new, higher, level. When this uoint is reached food _._ 
intake drops back to the lev e l necessary to retain the new 
weight. 
Further, Wade and Zucker [1 970 ] have demonstrated a 
depression of eating following implants of estrogen into th e 
VMH in ovariectomized females. Estrogen injected i.p. is 
known to affect electrical activity in a number of hypo-
thalamic nuclei but according to Faure and Vincent [1971], 
"The 'specific' estrogen-sensitive neurons were located 
strictly in the ventromedial nu c l eus and the posterior part 
of the lateral hypothalamus." Six of 11 VMH neurons which 
they studied s howed accelerated firing after estrone sulp hate 
injections. Twelve of 16 posterior lateral hypothalamic 
neurons reduced firing rate s in response to estrogen . 
On the basis of somewhat different analyses of the 
above data, very recent studies have looked directly at the 
weight effect of estrogen in VMH-lesioned animals . These 
studies are difficult to analyze, but Nance and Gorski 
[197 3] appear to have e liminated the es trogen weight effect 
in VMH - lesioned animals whil e King and Cox [1 973] and 
Reynolds and Bryson [1974] showed only a partial reduction 
in the estrogen weight effect. Th e lack of adequate locali-
zation studies of either the area responsible for VMH 
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weight effects or of the areas responsive to estrogen make 
difficult interpretation of a partial reduction in the 
effect of estrogen on weight. 
A large part of the normal suppressive effects of the 
VMH appears to be related to autonomic control of visceral 
(especially stomach and pancreas) function via the vagus. 
Hyperacidity and/or hyperinsulinemia may, in fact, account 
for the hyperphagic effects of VMH lesions [Powley and 
Opsahl,1974; Experiment l]. Recently Omole [1972] has 
provided data which may suggest the effects of estrogen on 
food intake are of a similar origin. Omole demonstrated 
increased gastric acidity following ovariectomy and during 
diestrus, periods during which there is a high level of food 
intake and low level of estrogen. Unfortunately, from 
Omole's data it is not possible to determine whether in-
creased acidity causes, or is caused by, the hyperphagia. 
Herner and Caul [1972], however, found higher ulceration in 
24-hour-deprived diestrus animals compared to similarly 
deprived ones in estrus. This may suggest that the in-
creased acidity is independent of food intake. 
The following mechanism of the effect of estrogen on 
food intake and weight is then possible. During periods of 
high plasma estrogen, estrogen-sensitive neurons in the area 
of the VMH are stimulated, and LHA neurons suppressed. High 
levels of VMH activity result in high blood glucose [Frohman 
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and Bernardis, 1971] and in low levels of both gastric 
acid [Misher and Brooks, 1966] and insulin [Frohman and 
Bernardis, 1971]. During periods of low estrogen the 
reverse is true. That is, during diestrus a condition of 
depressed VMH activity exists which mimics qualitatively 
the absence of firing occasioned by VMH destruction. 
With this mechanism in mind, the following demonstra-
tions are necessary. A relative hyperinsulinemia should 
accompany diestrus. Vagotomy should eliminate the cyclical 
weight changes as well as the basal insulin and acid dif-
ferences. 
The first experiment assessed the possibility of in-
sulin and glucose level changes paralleling the estrus cycle. 
5.2.1 Method 
Subjects were virgin, Wistar-derived, female rats 
obtained from the breeding colony of the John Curtin School 
of Medical Research (Canberra, Australia). The animals were 
housed individually in wire cages and maintained on free 
access to food and water. The colony temperature was 22 
±l.5°C and the lights were on from 0800 to 2000 hours. 
Smears were taken each day between 1000 and 1030 hours by 
insertion of a small, saline-wetted cotton bud into the 
vagina. The smears were then wiped onto clean slides, al-
lowed to dry and stained with methylene blue. At least 5 
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complete cycles were followed before blood sampling and all 
animals showed regular 4- or 5-day cycles. To avoid condi-
tioning effects only one blood sample was taken per animal. 
On the sample day food was removed from the cages at 0800, 
the smear taken at the normal time, and the samples obtained 
at approximately 1300 hours. The animal was removed from 
the colony room, quickly anesthetized with ether and blood 
withdrawn from the abdominal aorta. Total elapsed time 
between removal from cage to completion of sampling was 
never more than 3 minutes. An aliquot of the blood sample 
was immediately frozen for later insulin assay using the 
double-antibody radioimmunoassay technique. Owing to a lack 
of rat standard, values are reported in terms of human 
standard. Blood glucose was analyzed immediately using the 
ortho-toluidine method [Hyvarinen and Nikkila, 1962]. 
Four day cycles were designated as follows: proestrus, 
estrus, metestrus, and diestrus. Five day cycles had a 
second day of diestrus. Samples were taken at proestrus, 
estrus and the first day of diestrus. Statistical compari-
sons were made using a one-way, fixed effects analysis of 
variance on both plasma insulin and plasma glucose data 
followed , where appropriate, by Scheffe tests. 
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5.2.2 Results 
The data are summarized in Table 4. (Appendix K 
contains the F ratios.) Completely contrary to prediction, 
TABLE 4 
Plasma insulin (µU/ml) and glucose (mg %) levels (mean+ S.D.) 
of animals killed at 3 stages of the estrus cycle. 
Group 
Diestrus 
Proestrus 
Estrus 
N 
12 
18 
10 
Plasma Insulin 
61.0 + 16.3 
94.1 + 20.3 
90.8 + 22.0 
Plasma Glucose 
96.4 + 3.1 
100.0 + 4.0 
99.2 + 2.7 
animals in diestrus showed significantly (p < .02) lower 
insulin levels than those of both proestrus and estrus 
groups, which did not differ from each other (p < .20). 
Blood glucose did not change over the estrus cycle. 
5.2.3 Discussion 
The results of this experiment demonstrate that not 
only does the cycling female rat fail to display a relative 
hyperinsulinemia during diestrus, but tha t during this ph a se 
of high food intake and weight gain insulin levels are 
actually depressed. This result can be interpreted in two 
12 2 
ways. Either this preparation is not parallel to the VMH 
lesion, or hyperinsulinemia is not a necessary factor in 
VMH obesity (or, for that matter, in intake in the normal 
animal). It may be that hyperacidity alone is sufficient 
to drive the hyperphagia and obesity which follow VMH 
lesions. The following experiments explore this possibility. 
5.3 Experiment 13: Estrus Cycle and Gastric Acid - A 
Replication 
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Omole [1972] reported a relative hypersecretion of 
gastric acid at diestrus. The interpretation of this result 
is, however, obscured by a failure to control food intake. 
Thus, the high level of intake at diestrus may precede, 
rather than progress from, increased gastric acidity. The 
present experiment was designed essentially as a replication 
of the data of Omole [1972] under conditions of controlled 
food intake. 
5.3.1 Method 
Subjects and housing were as in Experiment 12. At 
least 5 complete cycles were followed before acid secretion 
testing and all animals showed regular 4- or 5-day cycles. 
Animals were deprived of rat cubes 24 hours before the acid 
secretion test but had free access to water. The procedure 
for collection of gastric acid was as in Experiment 2 with 
the exception that no insulin was injected and only two 
15-minute periods were observed. Groups of animals were 
testedF as in Experiment 12, at proestrus, estrus and the 
first day of diestrus. 
5.3.2 Results 
A one-way, fixed effects analysis of variance was 
carried out on the 30-rninutes acid secretion data shown in 
Table S. (Appendix L contains the F ratios.) In essence 
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the results confirm those of Omole [1972]. Scheffe compari-
sons showed total acid secretion was significantly elevated 
at diestrus compared to both proestrus and estrus (p < .01 
in both cases), and the latter two groups did not differ 
TABLE 5 
Basal acid secretion (µEq H+; mean over 30 minutes± S.D.) 
of groups of animals tested at 3 stages of the estrus cycle. 
Group 
Diestrus 
Proestrus 
Estrus 
N 
7 
8 
7 
significantly from each other. 
5.3.3 Discussion 
Acid secretion 
13.7 + 2.7 
4.6 + 1.6 
4.2 + 1.4 
These results are, at minimum, consistent with the 
notion that fluctuations in gastric acid secretion may be 
responsible f or the parallel changes in food intake and 
weight. Following this result it becomes important to 
demonstrate that vagotomy eliminates both the intake-weight 
and acid changes associated with the estrus cycle. 
5.4 Experiment 14: Estrus Cycle and Vagotomy 
The following experiment looked at the effect of 
subdiaphragmatic vagotomy on the estrus cycle weight, 
insulin and gastric acid secretion changes. 
5.4.1 Method 
Animals and housing were as in Experiment 12. 
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Cycling was followed for at least 3 complete cycles before 
vagotomy or sham vagotomy was performed. Surgery was 
carried out as in Experiment 1. Since vagotomized animals 
tended to continue a slight weight loss over 1 to 2 weeks 
following the operation, 4 weeks were allowed before initia-
tion of testing. By this time all animals had regained 
preoperative weight. Completeness of vagotomy was initially 
assessed using the method of Snowdon and Epstein [1970]. 
The liquid diet used was similar to that of Teitelbaum and 
Epstein [1962] and water was available ad libitum. Intake 
of the liquid diet was measured using a drinkometer circuit 
[Zucker, 1969] whose output fed into a Grass polygraph. 
A meal consisted of at least 15 seconds of sustained licking 
separated by at least 10 minutes from other bouts of licking. 
Drinkometer testing was over 3 consecutive days and meal 
frequency was assessed on the last of these 3 days. The 
schedule employed was as follows: operation, 4 weeks of 
recovery, 3 days in the drinkometer cages, 3 days to re-
acclimatize to their home cages and normal diet, weight 
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changes and smears over 5 to 6 cycles per animal, and 
finally blood sampling and acid secretion vagotomy testing. 
A number of measures of cyclical weight changes were 
assessed in pilot experiments. The simplest and most 
reliable proved to be weight change from the afternoon of 
diestrus (smears were taken between 1500 and 1600 hours) 
to the afternoon of estrus versus the weight change from 
estrus on to the first day of diestrus. This measure was 
consistent both for groups of females and for each indivi-
dual tested over at least 5 complete cycles and would thus 
seem preferable to invasive techniques such as ovariectomy 
and replacment therapy. 
Blood samples were taken and treated as in Experiment 
12 for determination of plasma insulin with the exception 
that blood was removed from the cut tip of the warmed tail 
under light ether anesthesia and the animal was allowed to 
recover. Two or 3 days following the blood sampling the 
animals were deprived of food cubes and treated as in 
Experiment 2. Two 15-minute periods of baseline data were 
collected. Insulin (2U/kg) was then injected subcutaneously 
and a further two 15-minute periods of acid secretion were 
collected and titrated. Half the vagotomized and half the 
controls were blood-sampled at estrus and acid-tested at 
diestrus; with the other half of the animals in both groups 
being treated in the reverse order. 
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5.4.2 Results 
Drinkometer and weight data are shown in Table 6. 
Only vagotomized animals whose meal f requencies were at 
least double that of the control mean and whose acid res-
ponses to insulin were absent are included in the table 
(see Experiment 2 for the crit e rion used to evaluate the 
TABL E 6 
Number of drinkometer meals (mean/24 hours, range in 
brackets) and weight changes (mean ±SD) over the estrus 
cycle for normal and va gotomi zed female rats. 
Weight Change (gms) 
Drinkometer Diestrus-to- Estrus-to-
Group N Meals Es trus Diestrus 
Control 7 12.9 (11 -15) -0.58 + 0.27 2.01 + 0.39 
Vagotomized 14 34.6 (26-41) -0 . 86 + 0.17 2. 2 5 + 0.26 
acid secretion test). No differences existed between control 
and vagotomized groups on either weight change from diestrus 
to estrus (t = 1.13; p > . 20 for a two-tailed test) or from 
estrus to diestrus (t = 0. 63; p > . 20 for a two-tailed test). 
If anything, the weight change spread over these 2 segments 
of the estrus cycle tended to be slightly larger in the 
vagotomized group (3.11 gms versus 2.59 gms for controls) . 
Of the 16 vagotomized animals which initially 
128 
satisfied the drinkometer criterion, 14 also had no acid 
response to insulin. It is possible that some regenera-
tion may have occurred in the other 2 animals between the 
time of the meal frequency and the insulin tests. Meal 
frequency would then still seem a reasonably good, 
atraumatic test to screen initially for completeness of 
vagotomy. 
The important result is the failure of vagotomy to 
affect the cyclic weight changes of the female rat. Thus, 
whatever the nature of these changes, they are not mediated 
by parasympathetic innervation of the viscera. Insulin and 
basal acid secretion are shown in Table 7. The insulin 
values are in line with those reported in Experiment 12 
TABLE 7 
Means and standard deviations of plasma insulin (wU/ml) and 
basal gastric acid secretion (wEq H+/30 minutes) for 
vagotomized female rats at either diestrus or estrus. 
Group 
Diestrus 
Estrus 
N 
7 
7 
Plasma Insulin 
79.9 + 9.8 
57.5 + l~.l 
Acid Secretion 
4.9 + 1.6 
3.8 + 2.0 
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(Table 4). The insulin level at estrus is significantly 
greater than at diestrus (t = 2.62; p < .05 for a two-tailed 
test). The mean insulin level for vagotomized animals was 
slightly lower than the controls of Experiment 12, the dif-
ference being more noticeable at estrus. The differences 
in basal acid secretion between estrus and diestrus are, 
however, eliminated by vagotomy (t = 1.00; p > .20 for a 
two-tailed test). 
5.4.3 Discussion 
Taken together, the results of this experiment: 
(a) demonstrate that vagal innervation of the viscera is 
not involved in maintaining the oscillations in weight and 
insulin which accompany the estrus cycle in the female rat, 
and (b) eliminate changes in basal acid secretion as res-
ponsible for these cyclical weight fluctuations. The 
possibility still remains that the fluctuations in insulin 
secretion are related to the rhythmic changes' in intake and 
weight. 
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5.5 Experiment 15: Estrus Cycle and Diabetes 
The fourth experiment in this chapter was designed to 
assess the effects of controlled insulin levels on the 
weight and food intake changes during the estrus cycle. It 
has previously been noted that induction of diabetes by 
alloxan interferes with estrus cycling [Davis, Fugo and 
Lawrence, 1947]; however, Prager, Abramovici, Liban and 
Laron [1974] reported no disruptive effect of diabetes in-
duced by streptozotocin. 
5.5.1 Method and Results 
Subjects and housing were as in Experiment 12. From 
4 to 5 cycles were followed before induction of diabetes. 
Animals were deprived overnight and injected with strepto-
zotocin (65 mg/kg i.p.). Food and water were then con-
tinuously available and smears were taken over the 2 weeks 
necessary for food and water intake and weight to stabilize. 
Contrary to the observations of Prager, Abramovici, 
Liban and Laron [1974], persistent diestral smears were 
observed in the diabetic animals beginning 2 to 13 days 
(mean 5.6) following streptozotocin injection. During the 
2 weeks following induction of diabetes, the an imals lost 
from 4% to 11% (mean 8.1 %) of their pre-injection body 
weight. To determine if this were the cause of the failure 
to cycle, a control group was deprived to 80% body weight 
over a 2-week period. This treatment failed either to 
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disrupt or lengthen the estrus cycle in these animals, 
results 1n agreement with those of Rosen and Petty [1974], 
who found no disruption even with deprivation down to 70% 
of body weight. 
5.5.2 Discussion 
This experiment fails to shed light on the problem 
for which it was originally designed. It is important for 
two reasons. First, it offers results not in agreement with 
those of Prager, Abramovici, Liban and Laron [1974]. Their 
dosage is below that normally used for induction of diabetes 
by streptozotocin and the form of diabetes thus induced 
may be peculiarly mild. 
More importantly, the cessation of cycling caused by 
the induction of diabetes is not dependent on weight loss. 
The results demonstrate that the diabetic animal is capable 
of a cessation of cycling to only marginal weight loss (some 
8%) while no disruption is observed in the normal animal 
reduced in weight as much as 30% [Rosen and Petty, 1974]. 
This difference may provide an important clue to the nature 
of protective metabolic adaptations available to the normal 
animal in the face of limited access to food, but apparently 
denied the insulin-deficient animal. 
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5.6 Discussion of Chapter Pive 
The research reported in this chapter was originally 
undertaken with the hope of establishing the estrus cycle 
of the female rat as a preparation which displayed the 
hyperphagia and obesity characteristic of the VMH syndrome 
(and for the same metabolic reasons) without the multiple 
problems associated with brain damage. As such the results 
are negative. Two experiments are critical in eliminating 
the diestral hyperphagia and weight gain of the female rat 
estrus cycle as a model of VMH damage. Experiment 12 showed 
that not only are insulin levels not elevated at the time 
of relative hyperphagia (diestrus) but are actually signi-
ficantly depressed compared to the periods of low intake 
and weight loss (proestrus and estrus). In addition, while 
vagotomy reverses the obesity and hyperphagia of the VMH 
preparation (Powley and Opsahl, 1974; Experiment 1), 
Experiment 14 showed that vagotomy has no effect on the 
relative hyperphagia and weight gain of the diestral phase 
of the estrus cycle in female rats. 
On the positive side there are several encouraging 
findings. The present results demonstrate that the weight 
fluctuations of the estrus cycle do not come about as a 
result of brain mechanisms acting via parasympathetic 
connections with the viscera. Thus despite the existence 
of "specific" estrogen-sensitive neurons in the two 
hypothalamic areas most closely identified with energy 
balance, their activity would not appear to be related to 
regulation of food intake and weight in the same vagus-
dependent manner as the classic VMH syndrome. Whether 
these estrogen-sensitive VMH cells have any relevance to 
weight regulation is still unclear. They may act via 
medullary or nervous sympathetic activity or indirectly 
via hormonal mechanisms. Alternatively, the estrogen ef-
fects may be of totally peripheral origin. 
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A second important point is with respect to the data 
of Experiment 12. The instability of the human diabetic 
during pregnancy and over the estrus cycle is well docu-
mented. Spellacy, Carlson and Schade [1967] investigated 
the basal insulin levels in human females over the estrus 
cycle and concluded that there were no changes in basal 
insulin which could account for this instability. The 
present data call for a re-examination of this conclusion . 
A species difference is possible, however,the results of 
Spellacy, Carlson and Schade cannot be accounted for in 
terms of suppression, due to social factors, of the ex-
pected weight increment at menstruation. Weight increases 
tend to raise basal insulin levels and thus would tend to 
obscure the relative hypoinsulinemia found at diestrus in 
the present experiments. 
This raises the third point. Recently a good deal of 
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attention has focussed on the role of insulin in the 
regulation of body weight. Thus Woods and Porte [1976; see 
also Bernstein, Kulkosky, Lotter, Porte and Woods, 1975] 
have pointed out the positive relationship between weight 
levels and basal insulin, with the implication being that 
these two measures not only covary, but that changes in 
basal insulin are causal in changing regulated weight levels. 
The results of Experiment 12 stand in direct contrast to 
the positive relationship described by Woods and co-workers 
and thus question the nature of that relationship. 
The low plasma levels of insulin at diestrus, while 
unexpected, may throw interesting light on the relationship 
between insulin levels and short- and long-term energy 
balance mechanisms. With repeated daily injection of in-
sulin hyperphagia results [Kumaresan and Turner, 1965; 
MacKay, Callaway and Barnes, 1940]. The overeating con-
tinues until a new level is reached and then food intake 
reduces to maintain this weight [Panksepp, Pollack, Krost, 
Meeker and Ritter, 1975]. This pattern is very similar to 
that seen following VMH lesions where hyperinsulinemia is 
seen to be correlated with the hyperphagia [Hustvedt and 
L¢v¢, 1972]. With the artificial induction of diabetes by 
streptozotocin, the interesting pattern of Experiment 8 
develops. The animal first reduces food consumption for a 
period of 2 days following injection. This, rather than 
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being due to illness because of the induction of diabetes, 
would seem to be an active suppression of intake. The 
induced diabetic, however, follows this hypophagic period 
with a steadily increasing hyperphagia which asymptotes at 
a chronically maintained high level. This occurs after 
obvious wasting of body tissue and would seem to reflect 
an imposition of the long-term control mechanisms based on 
some facet of this tissue loss. 
The insulin-food intake relationship could then be 
synthesized as follows. During both short (single injec-
tion) and long (repeated injections and following VMH 
lesions) periods of very hi gh insulin levels, hyperphagia 
and obesity result. During short-term induction of low 
insulin (anti-insulin serum, mannoheptulose, and the first 
2 days of induced diabetes) food consumption is low. How-
ever, with a longer period of low insulin (chronic diabetes 
mellitus) hyperphagia occurs, most likely as a long-term 
system's response to depletion of particular body tissues 
or critical rate of their breakdown, but with no need for 
insulin. 
It may be that the estrus-cycling female animal has 
adapted to fluctuating insulin levels (and persistent 
accumulation and degradation of tissue) by, for instance, 
anticipatory hyperphagia during diestrus to minimize tissue 
breakdown much in the manner of the hyperphagia of the 
chronic diabetic. 
CHAPTER SIX 
SYMPATHETIC NERVOUS SYSTEM CONTRIBUTIONS 
TO DIABETES MELLITUS 
6.1 Introduction 
The proposed model of VMH function may provide in-
sights of practical, clinical significance in three major 
areas of treatment of human disease. Of these, applica-
tions to diabetes mellitus are seen as perhaps the most 
important and are examined in this chapter. The possi-
bilities of applying the model to treatment of human obesity 
and to parental infusion of nutrient supply are considered 
in the discussion (Chapter Seven). 
Historically, the similarities between diabetes 
mellitus and sympathetic nervous system arousal have been 
well noted. Both involve abnormal pancreatic alpha and beta 
cell function (hypoinsulinffmia and hyperglucagonemia) and 
adjustment of body energy reserves and liver function 1n 
the direction of increased glucose manufacture and output 
(excessive lipolysis, proteinolysis, glycogenolysis, and 
gluconeogenesis with resulting hyperglycemia). Stress-
induced hyperactivity of the SNS exacerbates the diabetic 
syndrome. 
In spite of this, little attention seems to have been 
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paid to the possibility that the diverse metabolic ab-
normalities of diabetes mellitus owe their origin as much 
to a chronic high level of SNS activity as to a lack of 
insulin. 
Recently a number of lines of investigation have 
given an excellent basis for a closer look at this question. 
There is now ample evidence for neural control of pancreas, 
liver and fat deposits. The demonstrations exist at 3 
levels: anatomical evidence of neuronal investature of the 
organs themselves, the results of stimulation of the maJor 
nerves at points between the brain and their entrance to 
the organs, and, finally, results from direct stimulation 
of brain (particularly hypothalamic) sites associated with 
autonomic outflow. Prominent among these sites are the 
predominently sympathetic VMH and the parasympathetic LHA 
[Ban, 1964; 1966]. Interestingly, the activities in these 
two hypothalamic areas are often seen to be reciprocal 
[see Oomura, 1973]. 
The basis for autonomic nervous system control over 
pancreas has been generously established over the past 10 
years. There is ample evidence for a rich nervous supply, 
both adrenergic and cholinergic, to the alpha and beta 
cells [see Woods and Porte, 1974]. Miller [1975], using his 
"support-dog" preparation, has shown the overall effect of 
sympathetic nerve stimulation to be suppression of insulin 
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secretion, a conclusion supported by the results of Frohman 
and Bernardis [1971] with stimulation of the VMH. Frohman 
and Bernardis did, however, ascribe the whole of this sup-
pression effect to the adrenals. The effect of parasympa-
thetic (vagal) stimulation is to increase insulin output 
[Frohman, Ezdinli and Javid, 1967; Kaneta, Kajinuma, Kosaka 
and Nakao, 1968]. 
Sympathetic stimulation increases glucagon output 
[Marliss, Girandier, Seydoux, Willheim, Kanazawa, Orci, 
Renold and Porte, 1973]. There is some disparity in the 
parasympathetic stimulation results. Kaneta, Miki and 
Kosaka [1974] reported an increase in glucagon following 
dorsal vagus stimulation; however Marliss and co-workers 
[1973] were unable to block, with atropine, the glucagon 
increase they observed following stimulation of the mixed 
autonomic nerves. 
Though a direct nervous supply to the hepatocyte has 
only been demonstrated more recently [Tanikawa, 1968], 
Shimazu, Fukudu and Ban [1966] earlier demonstrated almost 
complete disappearance of liver glycogen following prolonged 
electrical stimulation of the VMH. Recently Shimazu and 
Ogasawara [1975] have shown that stimulation of the VMH 
results in an increase in phosphoenolpyruvate, a key gluco-
neogenic enzyme, and a decrease in pyruvate kinase, a key 
glycolytic enzyme. Sympathetic stimulation would then 
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appear to increase glycogen breakdown and gluconeogenesis 
while inhibiting glycolysis. The sum of these changes 
would be high blood glucose levels. Completing this pic-
ture is the finding that stimulation of the predominantly 
parasympathetic LHA results in a decrease in gluconeo-
genesis [Shimazu and Ogasawara, 1975]. In experiments 
concerning liver metabolism, the present issue is often 
complicated by differences between in vivo and in vitro 
preparations. For example, one can compare the differing 
conclusions about insulin effects on liver arrived at by 
Madison [1969] and Haft [1968]. Mortimore [1972] further 
reviewed these differences and pointed out the permissive 
effect of acetylcholine on glycogen deposition in the liver 
in the presence of insulin. 
The role of free fatty acids (FFAs) in diabetes is 
also one of controversy. Sympathetic innervation of adipose 
tissue has long been known [Boeke, 1933]. FFAs certainly 
influence the rate of gluconeogenesis and their release is 
particularly sensitive to neural control [Penick, Prince 
and Kinkle, 1966]. Using the alloxan diabetic as a 
preparation exhibiting a high rate of FFA efflux from adi-
pose tissue, Buckle [1963] was unable to show any effect of 
insulin on this rate of FFA release while Wertheimer and 
Shafrir [1960] reduced FFA rele a se to normal with the 
autonomic blocking agent "dibenzyline". In concert with 
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this latter finding, Correll [1963] demonstrated release of 
FFA upon sympathetic nerve stimulation. 
The second important series of results comes from 
work with the VMH. As pointed out previously, this struc-
ture is apparently unique (at least in the CNS) in that 
glucose uptake is insulin-mediated [Debons, Krimsky, Likuski, 
Cloutier and From, 1968; Smith, 1972]. Additionally, des-
truction of the VMH results in a syndrome that is charac-
teri zed by metabolic abnormalities which are chronically 
uncompensated, which depend on the vagus for their expres-
sion, and which are fairly strikingly reciprocal to the 
metabolic abnormalities of diabetes. Two reports have now 
demonstrated an amelioration of certain diabetic syndromes 
with alpha-adrenergic blocking agents [Cegrell, 1972; 
Robertson, Brunsell, Hazzard, Lerner and Porte, 1972]. 
Finally, the postulated i nsulin -glucoreceptor model of 
Chapter Three suggests a mechanism by which inappropriately 
low insulin levels would result in a chronically high level 
of VMH-generated SNS activity. To review, the basis of the 
proposed system is the insulin-mediated uptake of glucose 
in specialized VMH cells relevant to glucoregulation. In 
essence this means that the brain perceives its normal 
energy supply as "available" glucose, this being determined 
by both blood glucose and the insulin required for its 
uptake. This is quite reasonable under normal circumstances 
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since glucose is by far the most potent s timulus for in-
sulin secretion. However, in the diabetic case where 
insulin is only poorly secreted in response to glucose, the 
VMH uptake of glucose would be low and the CNS would 
"perceive" a much lower level of glucose than is existant . 
According to the model, SNS activity would remain high and 
the pattern of metabolic activity aimed at increasing blood 
glucose supply would be sustained. 
If this system is correct, then a reduction in 
activity and/or destruction of the peripheral sympathetic 
nervous system should relieve some of the metabolic problems 
of diabetes. The following experiments were designed as an 
initial assessment of this argument. 
Guanethidine sulphate (Ismelin, kindly supplied by 
CIBA-GEIGY) was chosen for treatment for several reasons. 
It is first of all a sympathetic blocking agent. As such it 
has a long history of human use for hypertension. As 
.previously pointed out, in addition to its blocking action, 
it has recently been found to effect near complete des-
truction of the peripheral sympathetic nervous system with 
chronic, high dosage treatment . This treatment appears to 
be without serious side effects. Finally, as it does not 
cross the blood-brain barrier, it has no central effect . 
6.2 Experiment 16: Sympathectomy and Diabetic Intake 
Utilization 
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This experiment was designed to look at one very 
general aspect of diabetes, the efficacy of utilization of 
intake. Diabetes mellitus induced with either streptozo-
tocin or alloxan is characterized by polydipsia, hyperphagia 
and some weight loss. The polydipsia is thought to reflect 
the amount of fluid necess ary to avoid renal collapse due 
to the hypertonicity of the glucose-laden blood. The hyper-
phagia would seem necessary to counteract the excessive 
tissue breakdown (which results in weight loss) and wastage 
of nutrients through urinary and fecal output. It was 
reasoned that if guanethidine sulphate sufficiently ameli-
orated any of the number of metablic abnormalities of 
diabetes, then this improvement would be expressed as a 
decrease in the amount of food and water needed by the 
diabetic animal to maintain a particular weight. 
6.2.1 Method 
Animals used were female, Wistar-derived rats ob-
tained from the breeding colony of the John Curtin School 
of Medical Research (Canberra, Australia) weighing approxi-
mately 200 gms at the beginning of the experiment. Diabetes 
was induced in 24 animals by a single injection of strep-
I 
tozotocin (65 mg/kg i.p. in citrate buffer pH 4.5) fol-
lowing an overnight fast. Sixteen control animals received 
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only buffer. All animals were then maintained on ad libitum 
access to food and water for approximately 2 months to 
ensure stable intake and weight. From gross observation of 
the diabetic animals it was apparent that the severity of 
diabetic effects covered an appreciable range. It was 
therefore decided to create 2 groups (1 group to receive 
guanethidine sulphate and the other physiological saline) 
matched on the basis of blood glucose levels. Following a 
4-hour fast animals were lightly anesthetized with ether and 
blood was taken from a cut at the tip of the tail. Blood 
glucose was analyzed by the ortho-toluidine method of 
Hyvarinen and Nikkila [1962]. On the basis of the glucose 
levels 2 matched groups of 7 diabetic animals each were 
formed. Guanethidine sulphate (GS) treatment was initiated 
one week following the blood glucose sampling. Treatment 
consisted of 6 weeks of daily injection with GS (25 mg/kg 
i.p . ) or saline [Burnstock, Evans, Gannon, Heath and James, 
1971]. Four groups were initially treated: diabetic 
animals given guanethidine sulphate (D-GS), diabetic animals 
given physiological saline (D-S), control animals given 
guanethidine sulphate (C-GS), and control animals given 
physiological saline (C-S). The original water intake, food 
intake and weight measures were based on the mean of the 
3 days prior to the initiation of treatment. Water intake 
was measured every fifth day, food intake every 2 weeks, 
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and weight daily for the 6 weeks of treatment and 3 weeks 
following cessation of injections . 
A fifth group of diabetic animals of comparable blood 
glucose level was added at the end of the first week whe n it 
was realized that water intake had dropped substantially in 
the D-GS group. This additional group (D-WR) had water in-
take restricted in the followin g manner. As each fifth 
day's intake was measured for the D-GS group , the intake was 
converted to a mean percentage of its original int ake . Eac h 
animal in the D-WR group was then allowed an amount of water 
equal to this mean percentage of the individual's original 
intake, the percentage being updated each 5 days . Water was 
available to the D-WR group throughout the dark period 
(1900-0700 hours), removed from 0800 to 1200 hours and then 
replaced at 1200 hours. The bottl e was invariably empty 
at 1900 hours when a new ration was given . The D-WR group 
was designed to assess the effect of a reduction in water 
intake on weight in diabetics not treated with guanethidine 
sulphate. 
Multigroup statistica l comparisons were made using 
one-way, fixed-effects analyses of variance at particular 
time points _followed by Scheffe te sts. 
6.2.2 Results 
The results are shown in Figures 14, 15 and 16 
(F ratios are summarized in Appendix iI). The important 
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Figure 14. The effect of guanethidine sulphate 
sympathectomy on the mean body weights of normal 
(C-GS; n = 8) and diabetic (D-GS; n = 7) female 
rats compared to normal (C-S; n = 8) and diabetic 
(D-S; n = 7) animals receiving only physiological 
saline. A diabetic group (D-WR); n = 5) was in-
cluded whose water consumption was paired to that 
of group D-GS. The dotted line beneath the 
abscissa indicates the 6 weeks or daily injections. 
•
 
0 
•
 
\ 
\ 
I I I I 
•
 
0 
•
 
\ 
\ 
I I I I 
•
 
0 
•
 
\ 
\ 
\ \ \ \ 
•
 
0 
•
 
\ 
\ 
I I I I 
0 
•
 
•
 \ 
\ 
I I I I 
•
 \ •
 
0 ("") 
N
 \ •
 \ •
o
 
0 
•
 
' 
e
:) 
r\ 
0 ,-N 
0 I I I 
II) 
II) °
' 
II) l!) 
II) (!) ~ 
I 
I 
I 
I 
I 
I 
() 
u
u
o
c
o
 
I 
e 
O
 
e O
D
 
11 
I I I 
I 
I I I 
I 
e 
O
 
e O
D
 
I 0 ' ' ' ' ' 0 I I I I 0 I I I I 0 
D
 
I 
•
 
I 
I 
I 
I I 
I I 
0 
D
 
I 
.. 
I 
I 
I 
I 
I 
'\ 
I 
I 
•
 
n
 
ll 
0 0 N I 
I
I
 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
•
 
() 
11 
-
' 
I 
,< 
I 
\ 
I 
,
'
 
\ 
I
,
 
\ 
e
u
 
(_) 
0 0-
0 co 
(sLU6) 1H
913M
 
1 46 
II) 
::a:: 
w
 
w
 
~ z w ~ -... 
("") Iv, (!) 
w
 
ex 
0.. 
!
,. i · ;-
• ,J; 
( 
i \ .. 
I .. _( ., k( 
!·-".' 
t: \ i _i 
f ' i ! · 
f I t, , 
i . .. 
r, •. 
. , 
r -· 
t
t·· _ ;_
. ~ . 
., . 
. 
. , 
;.J! 
hv I. , 
/: ' 
, .-!· L;: .,._ 
~( 
i/ 
t\ 
I~\· .,:\_. .,, \ / 
!,} '~ " . '\· \'( :,_._:~, ~· . . . ~~\ :_,~( .}Y r( ( 
·\·,·· 
'· ( 
' / .. 
Ill 
147 
Figure 15. The effect of guanethidine sulphate 
sympathectomy on the mean food intake of groups 
normal (C-GS) and diabetic (D-GS) female rats 
compared to normal (C-S) and diabetic (D-S) groups 
receiving only physiological saline. A diabetic 
group (D-WR) was included whose water consump-
tion was paired to th a t of group D-GS. The dot-
ted line beneath the abscissa indicates the 6 
weeks of daily injection. 
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Figure 16. The effect of guanethidine sulphate 
sympathectomy on the mean water intake of groups 
of normal (C-GS) and diabetic (D-GS) female rats 
compared to normal (C-S) and diabetic (D-S) 
groups receiving only physiological saline. The 
dotted line beneath the abscissa indicates the 
6 weeks of daily injection. 
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finding is a drop in food and water intake in the guanethi-
dine sulphate-treated diabetic animals to a level some 
70% to 75% of pre-treatment without loss of weight. This 
reduction in intake continued for the 3 weeks of observa-
tion following cessation of treatment . The water-restricted 
control group (D-WR) was discontinued after 4 weeks of 
restriction when they had lost a mean of 20 .8 grams. They 
were obviously deteriorating even after 2 weeks of restric-
tion despite having, at that time, a higher food intake 
than the D-GS group. 
Water and food intakes were significantly depressed 
(p < .01 1n all cases) in the D-GS group compared to con-
trol (D-S) at the time of the earliest measurement (3 days 
and 2 weeks of treatment, respectively) and remained so for 
the duration of the experiment. Weight was poorly matched 
between diabetic groups initially; however, a calculation 
of weight change for animals in groups D-GS and D-S from 
pre-treatment to 3 weeks following cessation of treatment 
(mean gain of 9 and 12 gms, respectively) showed the two 
groups to be not significantly different (p > .20). 
In summary, peripheral sympathectomy of the diabetic 
rat would appear to result in a substantial shift in the 
direction of more efficient utilization of incoming nut-
rients. This point is further examined and discussed in 
the following experiments of this chapter. 
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The effect of sympathectomy on intake and weight in 
the normal, adult animal does not appear to have been 
previously reported in detail. The control data may then 
be of interest. A significant depression of both intake 
measures and weight was evident by the second week of 
treatment in the C-GS group compared to the C-S group 
(weight and food intake, p < .01; water intake, p < .02). 
This is approximately the time when guanethidine sulphate 
would begin to accumulate and initiate significant destruc-
tion of the sympathetic nervous system. Whether or not 
the depression in intake and weight was the result of this 
destruction or a side effect of the drug, intake measures 
returned to normal by the end of treatment, and weight, 
while still reduced (p < .05), appeared to be returning to 
control levels. Peripheral sympathectomy would then seem 
to have little long-term effect on intake or body weight in 
the adult, female rat, a conclusion in concert with that 
reached for the male rat (Experiment 3). 
6.3 Experiment 17: Sympathectomy, Ganglionic Block and 
Diabetic Blood Glucose 
As mentioned in the introduction to this chapter, 
guanethidine sulphate produces a relatively short-term 
ganglionic block following a single injection as well as 
eventual SNS destruction. This experiment looked speci-
fically at blood glucose changes as a function of these 
two actions. 
6.3.1 Method 
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The effect of SNS destruction was assessed on the 
animals of Experiment 16. Blood glucose was originally 
determined 1 week before treatment and a second sample was 
taken 4 weeks after treatment. No serial determinations 
throughout treatment were attempted, as diabetic animals 
react badly to the stress of blood sampling and it was felt 
this would seriously confound the intake and weight 
measures. 
Blood glucose changes induced as a result of the 
ganglionic blocking action of GS were determined on separate 
groups of animals made diabetic as in Experiment 16 and 
closely matched for blood glucose levels. Two short-term 
experiments were run. Blood glucose was measured 6, 24 
and 72 hours following a single injection (100 mg/kg i.p.) 
of GS in one group of diabetic animals. A further group 
of diabetic rats were given daily injections (100 mg/kg 
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i.p.) for 4 days and glucose was again measured 6, 24 and 
72 hours after the last injection. The control group was 
given 4 days of saline injections and therefore is most 
strictly comparable to this latter group. In all groups 
food was not available for 4 hours before each blood 
sampling. Blood was always withdrawn from the cut tip of 
the tail under light ether anesthesia and glucose analyzed 
by the ortho-toluidine method of Hyvarinen and Nikkila 
[1962]. 
6.3.2 Results 
The effect of SNS destruction on diabetic blood 
glucose levels is shown in Figure 17A. Blood glucose of 
sympathectomized diabetic rats was reduced by 22.3% 4 
weeks following cessation of treatment while controls were 
not significantly affected. The post-treatment difference 
was significant at the 0.01 significance level. 
The data from the short-term experiments are shown 
1n Figure 17B (see Appendix N for the F ratios). A single 
injection of GS (100 mg/kg) caused a significant drop in 
blood glucose of 28.3% within 6 hours (p < .01 compared to 
control). As judged by ptosis in mice, a single injection 
of GS _should still be maintaining maximal ganglionic block 
at that time [Fielden and Green, 1965]. A slight reduction 
in blood glucose was still evident 24 hours following in-
jection but, due to a large variability, failed to reach 
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Figure 17A. Plasma blood glucose of diabetic, 
sympathectomized (D-GS); n = 7) and diabetic, 
physiological saline-injected (D-S; n = 7) groups 
prior to, and 3 weeks following, treatment. 
Figure 17B. The effect of a single 100 mg/kg in-
jection of guanethidine on blood glucose of 
diabetic animals 6, 24 and 72 hours following 
that injection (D-GS-1; n = 6) compared both to 
a control, saline-injected group (D-S; n = 4) and 
a group whose blood glucose was measured 6, 24 
and 72 hours following the last of a series of 
4 daily 100 mg/kg guane thidine injections (D-GS-4; 
n = 6) . 
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statistical significance (p > .10). Glucose had returned 
to normal by 72 hours. With a 4-day series of injections, 
glucose was down by an amount comparable to the single 
injection group at 6 hours (p < .01 compared to control) 
and still significantly down at 24 hours following the last 
injection (p < .05). The decrease at 72 hours was not 
significant (p > .10). 
6.3.3 Discussion 
The results of this experiment confirm the role of 
the SNS in control of blood glucose in the diabetic, both 
via acute ganglionic block and chronic destruction. 
It is of great interest whether sympathectomy (or SNS 
block) results strictly in a reduction in blood glucose or, 
in addition, acts to stabilize the damaging fluctuations 
in glucose levels which plague the diabetic. A good deal 
of the present diabetes research is being done on the 
creation of an artificial pancreas arrangement whereby 
blood glucose is repeatedly determined and insulin injected 
automatically in appropriate amounts. While administra-
tion of insulin in small, discrete doses in response to 
current glucose levels certainly represents a marked ad-
vance over the presently accepted "big hit" f orm of insulin 
administration, it may be,recalling the model generated in 
the discussion of Chapter Three, that the anticipatory na-
ture of the cephalic portion of insulin secretion will 
frustrate this approach. 
6.4 Experiment 18: Sympathectomy and Diabetic Plasma 
FFAs 
There are numerous mechanisms by which ganglionic 
block or sympathectomy induced by guanethidine sulphate 
might reduce blood glucose. As pointed out previously, 
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the availability of free fatty acids (FFAs) certainly in-
fluences, as substrate, the rate of gluconeogenesis in the 
liver. It has long been known that ganglionic block in-
duced by "dibenzyline" reduces the efflux of FFAs from the 
adipose tissue of diabetics [Wertheimer and Shafrir, 1960]. 
The present experiment extended this finding to guanethi-
dine sulphate (GS). 
6.4.1 Method 
Animals and induction of diabetes were as 1n 
Experiment 16. Blood was collected from a tail vein under 
light ether anesthesia, the lipid portion of the blood was 
extracted with chloroform -methanol, and FFAs were analyzed 
by the method of Duncombe [1963]. All blood sampling was 
done between 1600 and 1700 hours on 9- to 10-hour deprived 
animals. Four groups of diabetics were run. In 2 groups 
food was removed at 1700 hours of the second day following 
induction of diabetes, and either GS (100 mg/kg i.p.; 
n = 4) or physiological saline (n = 6) injected. Blood 
sampling was done the afternoon of the same day. In the 
other 2 groups either GS (100 mg/kg i.p.; n = 7) or an 
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equivalent volume of saline (n = 6) was injected each day 
at 1600 hours for days 8, 9, 10 and 11 following induction 
of diabetes. Food was removed at 0700 hours on day 12 
and blood sampled that afternoon. 
6.4.2 Results 
The results are shown in Figure 18. Plasma FFAs were 
reduced both 10 hours following a single injection of GS 
(t = 11.03; p < .01 for a two-tailed ~est) and 24 hours 
following a 4-day series of GS injections (t = 2.81; p < .0 2 
for a two-tailed test). This confirms, for GS, results 
obtained with dibenzyline. 
6.4.3 Discussion 
The reduction in plasma FFA's most likely reflects 
a decrease in efflux from fat stores. Such a decrease 
would obviously be important to the diabetic both as protec-
tion against depletion of body energy reserves and in 
slowing the rate of gluconeogenesis and hence reducing 
both blood glucose levels and tendency to ketosis. 
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Figure 18. Plasma free fatty acid levels of 
9- to 10-hour deprived normal and diabetic ani-
mals. Blood sampling was done on the diabe t ic 
animals either 2 days following induction of 
diabetes with streptozotocin and having had 
either 100 mg/kg of guanethidine (dark cross-
hatching) or physiological saline (open bars) 
injected at the beginning of the fast or 1 2 days 
following induction of diabetes and 24 hours fol-
lowing the last of a series of 4 daily 1nJec-
tions of either guanethidine (100 mg/kg) or 
saline. 
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' 6.5 Experiment 19: Sympathectomy and Diabetic Liver 
Glycogen 
A proper analysis of the effect of sympathectomy on 
all aspects of liver metabolism was beyond the scope of 
this thesis. However, Shimazu, Fukuda and Ban [1966] have 
demonstrated that prolonged electrical stimulation of the 
VMH results in depletion of liver glycogen. As a reasonable 
compromise, therefore, liver glycogen was assessed in the 
4 major groups of animals in Experiment 16. It was antic-
ioated that sympathectomy might eliminate th e neural 
glycogenolytic influence, allowing a rebuilding of the liver 
glycogen reserves in the diabetic animal. 
6.5.1 Method 
Subjects were the animals of the 4 maJor groups of 
Experiment 16. Five weeks following cessation of treatment, 
and 1 week following the last blood sample, animals were 
lightly anesthetized with ether and the liver removed as 
quickly as possible. The liver was dropped onto a frozen 
petri glass after brief washing in cold water and blotting, 
and weighed to the nearest 0.01 gm. A section of approxi-
mately 200 mg was then cut from the center of the maJor 
lobe, weighed to the nearest 0.0005 gms and immediately 
homogenized with 20 mls of 5.0% TCA. Liver glycogen was 
analyzed according to the iodine method of Van der Vies 
[1954]. one-way , fixed effects analysis of variance 
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was carried out on both liver weight and glycogen data 
followed by Scheffe individual comparisons. 
6.5.2 Results 
Liver weights and glycogen content are reported in 
Table 8 (see Appendix P for F ratios). Livers were signi-
ficantly heavier in the <liabetic groups compared to their 
TABLE 8 
Liver weight and glycogen content (mean± SD) of sympathec-
tomized diabetic and sympathectomized normal animals and 
their respective control groups. 
Liver glycogen 
Group Liver wt. (gms) (% 1vet weight) 
Diabetic-sympathectomi zed 10.08 + 1.26 1.39 + 0.83 
Normal-sympathectomized 8.06 + 0.58 3.13 + 0.59 
Diabetic-control injected 10.99 + 0.95 1.81 + 1.06 
Normal-control injected 8.43 + 0.73 3.38 + 0.48 
respective controls (p < .01 in both cases). There were no 
differences between diabetic groups or between control 
groups. Liver glycogen in both diabetic groups was con-
siderably reduced compared to controls (p < .02 in both 
cases). However, contrary to prediction, sympathectomy 
not only failed to ameliorate the glycogen deficiency of 
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the streptozotocin diabetic, but the trend is in the op-
posite direction. It is interesting to note that sympathec-
tomized control animals also have a non-significant (p < .10) 
tendency towards smaller livers and less glycogen per gm 
of liver. 
6.5.3 Discussion 
The results of this experiment demonstrate that 
sympathectomizing diabetic animals whose liver glycogen is 
already greatly reduced does not result in any repletion 
of the liver glycogen reserve. It may be more reasonable 
to expect that inducing diabetes in already sympathectomized 
animals or initiating GS tr eatment immediately upon induc-
tion of diabetes would limit the depletion of liver 
glycogen. 
The results are, how ever, interesting from two other 
points of view. First, sympathectomy tends to reduce the 
excess liver weight which accumulates in the diabetic. As 
this enlargement is likely to reflect the excessive gluco-
neogeni c demands made on the diabetic liver, the result 
supplements those showing decreased gluconeogenic substrate 
[Experiment 18] and apparent glucose output [Experiment 17] 
following sympathectomy. 
.• 
Second, while the results of 
Shimazu, Fukuda and Ban [1 966, cited in the introdution 
to this experiment] suggest that sympathetic arousal has a 
glycogenolytic effect, the present results demonstrate that 
basal levels of SNS activity do not function to limit 
glycogen reserves. 
165 
6.6 Discussion of Chapter Six 
The intake and weight data along with the data on 
blood glucose and FFAs would appear to mean a shift away 
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from glucose output and towards more efficient conservation 
of body tissue and utilization of incoming nutrients. As 
this work is of an exploratory nature, little can be said 
about where in the metabolic systems the advantageous changes 
are taking place. There are a number of candidates. 
As pointed out in the introduction to this chapter, 
sympathetic nerve stimulation can cause the release of 
glucagon [Bloom, Edwards and Vaughan, 1973; Marliss, Girar-
dier, Seydoux, Wolheim, Kanazawa, Orci, Renold and Porte, 
1973] and, where there is a certain level of residual insulin 
secreting capacity, this potential may be under active 
inhibition [Frohman and Bernardis, 1971]. 
The stimuli for mobilization of body fat may be 
largely of neural origin. Reducing FFA efflux by sympa-
thetic block would limit gluconeogeneis. The decreased 
plasma FFAs may then account for the reduction in blood 
glucose. It has been generally presumed that the osmotic 
changes produced in the blood by hi gh levels of glucose, and 
the water necessarily excreted in order to eliminate this 
glucose, accounted for the diabetic polydipsia. The reduc-
tion in blood glucose (whether by reduction in rate of 
gluconeogenesis or by some other mechanism) would account 
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at least for the drop in water intake. Food intake is more 
difficult. The hyperphagia of the diabetic presumably 
reflects the influence of a long-term body reserve regula-
tion [Experiment 8]. Until the nature of this long-term 
system is established it will be impossible to say which 
metabolic effects of GS are responsible for the decrease 
in food intake. 
Liver enzyme activity may be directly altered from 
excessive glycogenolysis and gluconeogenesis. Certainly it 
has been demonstrated that glycogen breakdown [Shimazu, 
Fukuka and Ban, 1966] and critical enzymes in the gluco-
neogenic and glyco l ytic pathways in the liver [Shimazu and 
Ogasawara, 1975] can be significantly modified by changes 
in hypothalamic activity. The whole question of the effect 
of insulin on handling of glucose by the liver is a diffi-
cult one. Certainly in vivo and in vitro types of prepara-
tions give dramatically different results [see, for example, 
Haft, 1968; and Madison, 1969]. While a discussion of these 
differences and the reasons for them is completely beyond 
the scope of this thesis, the following points may be made. 
In general there seems little doubt that insulin has a 
large effect on a range of liver functions. In vitro those 
effects are often difficult to demonstrate. For example 
Mortimore [1972] states that it appears that "insulin has 
little or no effect on glucose uptake and glycogenesis. On 
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the other hand, evidence from the intact animal clearly 
indicates that insulin is capable of stimulating glycogen 
synthesis ti. He then goes on to say, "One clue to a possible 
explanation has come from a report that glycogen synthetase 
activity increases after vagal stimulation in vivo 
[Shimazu, 1967]. Following this observation, Mondon et al. 
[Mondon and Burton, 1971] noted that glycogen deposition in 
perfused livers of fasted rats is greatly increased by 
insulin in the pre sence of ace t ylcholine and approaches 
rates of deposition seen in the intact rat. The possibility 
of neural influences cannot be ignored, and, if Mondon's 
findings are confirmed, one must consider the action of in-
sulin in relation to the autonomic function of liver." 
These comments by Mortimore represent one of the very few 
references to insulin effect on liver function in terms of 
neural input. That this approach seems largely ignored 
probably reflects the ov erwhelming complexity of assessing 
the effect of change in one hormone in vivo. A cross-
perfusion system along the lines of that employed by Bergman 
and Miller [1973] may provide the basis for at least a 
partial solution to the problem. This system would allow 
the manipulation of au tono mic activity on an organ in situ 
with normal neural connections but whose blood supply was 
independent. 
Finally, the present findings focus attention on the 
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role in diabetes of that portion of the autonomic nervous 
system whose prime function has been classically seen as 
mobilizing the body's resources in face of both internal 
and external stressors. As such the SNS may play its most 
devastating role in diabetes during the onset period of the 
juvenile form of diabetes mellitus. This period can rougly 
be characterized as follows. The person destined to become 
a juvenile diabetic is usually first admitted to hospital 
in, or near to, an insulin deficient coma. Treatment with 
insulin is effective in relieving the acute problem and 
the patient is usually discharged regulating blood glucose 
"normally" without the necessity, at this time, for insulin 
treatment. The relapse generally occurs some weeks, or even 
months, later and this _time a full-blown, chronic, insulin-
dependent diabetes results. As well as generally occurring 
around the time of the hormonal changes of puberty, the on-
set episodes often occur at times of other overt mental or 
physical (injury or illness) stress. 
Unhappily, no animal model now exists which even 
approximates the onset symptoms of the juvenile diabetic. 
However, the rat made abruptly diabetic with streptozotocin 
does exhibit many of the metabolic features of the juvenile 
onset period, including hyperglycemia, some degree of 
ketosis and severe wastage of body tissue. It would be of 
interest to determine whether ameliorating these onset 
symptoms by, for example, prior sympathectomy would have 
even more substantial long-term remedial effects. 
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Further, it has recently been demonstated that a pre-
disposition to diabetes is apparently produced by neonatal 
administration of subdiabetic doses of streptozotocin 
[Portha, Levacher, Picon and Rosselin, 1974]. Stress, in 
these animals, may be sufficient to induce diabetes and 
thus yield a more appropriate model for juvenile onset. 
Studying the effects of controlling SNS activity in such a 
model may prove rewarding. 
CHAPTER SEVEN 
GENERAL DISCUSSION 
The maJor argument presented herein is that the bulk 
of the data generated by various manipulations of the VMII 
can be accounted for by assuming a direct role for the VMH 
in glucoregulation. The postulated receptor system is con-
sistent with a good deal of data and the model, in general, 
would seem both to be cohesively logical and of some predic-
tive value. A basis for its application to diabetes is 
provided in Chapter Six. As pointed out in the introduction 
to that chapter, diabetes is one of three areas of practical 
importance to which the model could be applied. In addition, 
although beyond the scope of this thesis, its relevance 
to neurogenic control of weight regulation and to the prac-
tice of complete alimentation of patients by the intra-
venous route should be explored. 
7.1 Neurogenic control of weight regulation 
The present argument may provide an anatomical basis 
for the phenomenon described by Nisbett [1972], Sc hacht e r 
[1971] and Stunkard [1968]. These authors discuss data 
concerning "environmental" influences on food intake and 
suggest that obese people are more responsive to external 
cues than normals. Thus obese subjects were found to be 
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significantly more susceptible to the inrlu e n c cs o[ the 
social, cognitive, situational, and gustatory-quality 
aspects of nutrient ingestion. The specific suggestion of 
these authors is that, however it occurs, the obese person 
is biased toward responding to the external, ratl1er than 
internal, cues associated with food intake. 
Using the model of VMH function generated in this 
thesis, this suggestion can be interpreted as follows. In 
the "normal", non-obese animal ingestion of a familiar food 
will provide a series of metabolic responses which, in 
previous experience, have been found to result in: 
(a) reasonable post-prandial nutri en t supply, and (b) stable 
long-term weight maintenance. With each novel food the 
appropriate series of metabolic responses must be redeter-
mined. While it seems likely that the gus tatory qualities 
of the novel food will initially bias both the amount 
ingested and the metabolic responses, the caloric value of 
the new food will eventually be felt. Thus, in the case of 
a neutral-tasting, calorically-dense food, the initial 
response would be, for instance, an insufficient secretion 
of insulin and the aversive consequence of a relative hyper-
glycemia. The alternatives available for subsequent meals 
are then either to: (a) reduce intake of the calorically 
more dense food, or (b) increase the metabolic (e.g., 
insulin) response and consume the same amount, ignoring 
..... 
--
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the long-term consequences (i.e., obesity) of such a course 
of action. The VMH, by the model generated in Chapter Three, 
is seen as a major influence both in the evaluation of the 
sensory qualities of the food and in making the appropriate 
metabolic adjustments. The VMH-lesioned animal is then 
seen, from this view, to represent the most gross case 
where an oversecretion of insulin results · from ingestion of 
food creating an aversive hypoglycemic result. Denied the 
alternative of reducing the physiological response, the 
animal is forced to consume larger and larger amounts of 
food to the point of exhausting insulin supply. 
It may be, then, that the obese person, either through 
physiological abnormality or maladaptive learning, has 
depressed VMH responsivity to stimulus conditions associated 
with food ingestion. Thus the obese person, like the VMH-
lesioned animal, may respond to a relative oversecretion of 
insulin (and the aversive aftereffects), not by reducing 
insulin output, but by increasing food intake. Booth and 
his co-workers have suggested that people may be trained 
to greater sensitivity for the carbohydrate content of their 
diet by giving them verbal feedback on what they have eaten 
and asking them to note carefully their internal sensa-
tions . Booth, Lee and McAleavey [1976] have demonstrated 
that man, like the rat, can learn to use a food's flavor 
to anticipate satiating aftereffects. If this acquired 
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sensory satiety involves adapting the insulin secretory 
response, then it may be possible to use more direct and 
powerful biofeedback. Although rapid monitoring of insulin 
levels is at present not technically feasible, it may be 
possible to use gastric motility and/or pH as manipulable 
biofeedback phenomena correlated with the insulin response. 
7 . 2 Intravenous feeding and caloric regulation 
The science of parenteral alimentation (the feeding 
of the entire nutrient supply by routes outside the ali-
mentary canal, generally intravenously) is still relatively 
primitive. Achievements of satisfactory infusion mixtures 
over long periods of time are rare. Apart from the obvious 
failure to infuse essential amino acids and fatty acids, 
the recent report of Oohktens, Marsh, Smith, Bergman and 
Yates [1974] provides dramatic evidence of the anti-
regulatory effect of continuous, long-term infusion of 
carbohydrate (typically given in humans via a destrose-
saline infusion mixture). 
A wide range of diet compositions can be orally 
ingested without significant fluctuation in calories of 
intake or weight [see Harper and Boyle, 1976]. Within those 
bounds any addition (by gastric, duodenal, or intravenous 
infusion) of nutrient to total energy supply would seem, 
logically, to be capable of compensation. Thus, if the 
.I 
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addition of glucose to an animal either intravenously or 
intragastrically does not require a reduction in oral intake 
of a magnitude such that supply of protein or essential 
fatty acids is critically impaired, then there should be 
perfect compensation (by reduced oral intake) for the 
caloric value of that infused glucose. 
The initial study which explored this question 
[Adair, Miller and Booth, 1968], using continuous infusion 
intravenously (i.v.) over a period of days, reported ab-
solutely no compensation for the infusion of 27.5 mls of 
30% D-glucose per 24 hours (a rate which they calculated 
should raise the plasma level of glucose some 125 mg%). 
These negative results were replicated by Scharrer, Thomas 
and Mayer [1974] again using continuous i.v. glucose 
infusions. Additionally, these authors reported no effect 
of meal-tied glucose infusions. The amounts they infused 
1n this latter experiment, however, represented only the 
addition of some 0.2 to 0.3 kcal of energy to meals 
averaging 4 to 5 kcal. The infused amounts are less than 
the standard errors which they report for meal size . Under 
these conditions any significant effect would be unlikely . 
More recently Rowland, ~1eile and Nicolaides [1973; 
1975] have reported depression ratios (DR, calculated as 
depression in intake (kcal)/amount infused (kcal); no com-
pensation then yields a DR= 0 and perfect compensation 
--
-
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DR= 1) of some 0.42 to 0.52 for glucose infused con-
tinuously. That represents a reduction in intake of 
approximately half the amount infused. With the addition 
of a parallel infusion of 10 I.U. of insulin per 24-hour 
period the DR to i.v. glucose rose to precise compensation 
at 1.00. In a further extension of these results [Rowland, 
Meile and Nicolaides, 1975] the DR to i.v. glucose in VMH 
lesioned rats was shown also to be 1.00. They interpret 
these findings as meaning that the imperfect compensation 
in the normal animal is due to insufficient secretion of 
insulin to a glucose load which bypasses the orogastro-
intestinal system. They suggest this is not a problem in 
the VMH lesioned animal who is already markedly hyper-
insulinemic and whose insulin secretory apparatus has 
presumably undergone sufficient hypertrophy to allow an 
adequate insulin output to the added glucose load. 
An alternative explanation follows from the role of 
the VMH in glucoregulation as developed in the discussion 
of Chapter Three and hinges upon the study of Oohktens, 
Marsh, Smith, Bergman and Yates [1974] showing that marked 
oscillations in plasma insulin and glucose occur as a 
result of continuous i.v. glucose infusion. In the normal 
animal I have hypothesized that the VMH acts to stabilize 
energy (particularly glucose) supply to the CNS. It is seen 
to do so by: (1) augmenting pancreatic insulin secretion 
--
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(and, most reasonably, reducing both hepatic glucose produc-
tion and efflux of FFAs from adipose) to the anticipation 
of a meal, thus creating a situation minimizing destruc-
tion of endogenous energy reserve and maximizing efficient 
disposition of the incoming nutrient, and (2) suppressing 
the reactive phase of insulin secretion which is driven 
first by the gastrointestinal vago-vagal reflexes and 
secondly by the actual perfusion of the pancreas by nutrient 
enriched blood. The suppression of these insulin-secreting 
phases (combined, most likely, with augmented hepatic 
glucose production) avoids any hypoglycemic overshoot. 
It seems reasonable, then, to hypothesize that the 
failure of Nicolaides and Rowland [1975], Adair, Miller 
and Booth [1968] and Scharrer, Thomas and Mayer [1974] to 
observe perfect, or near perfect, compensation for the 
glucose continuously infused resulted, not from a failure 
to secrete adequate insulin to dispose of the glucose 
efficiently, but from the generation of energetically 
wasteful futile cycles of glycogen and fat synthesis fol-
lowed by degradation. These cycles are seen to be generated 
by the VMH as a result of an inappropriate sequelae of 
events (or, more appropriately, lack of events) surrounding 
the occurrence of increased blood glucose levels. In the 
case of the VMH lesioned animals, these oscillations would 
be absent and the only abnormality would be the supranormal 
-
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insulin response to the infused glucose, a situation which 
should result in its efficient utilization. It would seem 
then that in the normal animal perfect compensation for 
the caloric value of glucose infused i.v. might be achieved 
either by some form of autonomic nervous block (sympathetic 
or parasympathetic depending on the nature of the VMH 
output pathways) or by tying the infusions to naturally 
occurring meals in such a way as to mimic the normal time 
course of blood glucose rise following such meals. 
Three studies, using intragastric or intraduodenal 
infusions, are relevant to the hypothesis that perfect com-
pensation for infused nutrient might depend heavily upon 
the temporal pattern of the infusion. Quartermain, Kissi-
leff, Shapiro and Miller [1971] report relatively good 
caloric compensation with complete diet infusion which were 
designed either to mimic the natural meal pattern of the rat 
or given 10 minutes before each meal of a forced meal 
pattern (15 minutes access to food each 3 hours). Their 
intragastric infusions were administered through a naso-
pharyngeal tube. They may, therefore, have maximized com-
pensation by signalling the onset of an in f used. "meal" by 
a change in the characteristics of the tube (i.e., volume 
or temperature). The studies of Thomas and Mayer [1968] and 
Snowdon [1975] come closest to the proposed periprandial 
i.v. infusions. Both used the nasopharyngeal tube and 
-
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infused liquid diet or glucose each time the animal pressed 
a bar for a portion of the oral diet. The overall results 
appear to provide poor support for the above hypothesis but 
the data may be misleading. Thomas and Mayer, for example, 
give a single figure representing the mean caloric intake 
over the first 3 days of periprandial infusion. The caloric 
compensation is little better using periprandial rather than 
continuous infusion over the total of these 3 days (DR= .75 
vs .. 73). However, the individual data for a single animal 
presented in their Figure 5 show a progressive decline in 
excessive caloric intake over the 4 days shown to a point 
of perfect compensation by day 4 of periprandial infusion. 
This is in contrast to the results of icolaides and Rowland 
[1975] who found no change in the degree of compensation 
after the first day of infusion. The basis for the 
relatively long delay to compensation in the Thomas and 
Mayer [1968] study may lie in the absence of a discriminable 
change in the characteristics of the ingested food versus 
its metabolic consequences. In other words, it may be more 
difficult for an animal to alter the set of its metabolic 
responses to a diet with which it is already familiar (and 
to which it has metabolic responses of a particular magni-
tude which have been reinforced previously by pleasant 
aftereffects than to a diet which has, at least, novel 
sensory characteristics. This could easily be tested. 
However, even if perfect caloric compensation could be 
ll 
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demonstrated for intragastric infusions by tying the in-
fusions to normal meal patterns and by maximizing signal 
value, then the question would still remain as to whether 
the gastrointestinal reflexes are necessary for complete 
utilization of incoming nutrient. 
In summary, speaking to the point of caloric regula-
tion, it has still to be conclusively demonstrated that i.v. 
infusion of glucose does not result in a reduction of intake 
equal to the caloric value of that infused glucose. Rather, 
the negative results thus far reported can be questioned 
on the grounds that such infusions generate metabolically 
wasteful synthetic-degradation cycles and/or require reduc-
tions in oral intake below that necessary to obtain suf-
ficient protein and essential FFAs. 
Secondly, and of far broader import, millions of 
hospital patients are routinely maintained on continuous 
i.v. infusions of dextrose-saline for extended periods of 
time. If the findings of Oohktens, Marsh, Smith, Bergman 
and Yates [1974] are found to apply equally to humans, then 
it is apparent that these patients are being subjected to 
conditions of alternating hyperglycemia and hypoglycemia 
with th e obvious potential for severe nervous tissue damage. 
The model for VIvlH function proposed in this thesis may 
provide both the means of understanding the phenomenon and 
a direction for research aimed at alleviating the problem. 
.... 
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7.3 Summary 
Major points concerning the reinterpretation of the 
VMH role in energy balance can be reiterated as follows. 
The VMH is seen to stabilize glucose supply to the brain. 
It does so by initiating a series of metabolic actions 
(at least including the augmenting of insulin production, 
decreasing hepatic glucose output and reducing free fatty 
acid efflux) at the onset of a meal which prepare the 
animal for nutrient disposal and thus minimize the surplus 
of circulating nutrients attendant upon a meal. During, 
and immediately after, the meal, even while blood glucose 
is high, the VMH steadily reverses this metabolic pattern 
to anticipate the blood glucose fall and avoid a hypogly-
cemic overshoot. The VMH accomplishes the.se functions 
primarily via vagal output from receptors responsive to 
meal-related sensory events and blood-borne insulin and 
glucose concentrations. 
The VMH is seen to have a role in the control of food 
intake only in so far as food intake (increase or decrease) 
is an important, but likely to be an emergency, gluco-
regulatory mechanism. It seems reasonable to presume that 
in an animal with ad libitum access to food, intake would 
anticipate deficit and therefore not normally occur as a 
glucoregulatory device. 
There would appear to be no good evidence that the 
I 
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VMH is involved in long-term body weight regulation. The 
results of the investigation into diabetic hyperphagia 
[Experiment 8] are interpreted as separating the effects of 
the VMH insulin-glucoreceptor from the systems monitoring 
body energy reserves. The observation that VMH-lesioned 
animals plateau at, and actively maintain, a particular 
body weight is reinterpreted as the outcome of a failure to 
suppress insulin secretion which occurs following the blood 
nutrient rise attendant upon a meal. To the degree that 
this inhibition is impaired, the oversecretion of insulin 
will drive incoming nutrients into fat, depleting readily 
available nutrient supply and entraining further intake. 
The particular body weight arrived at by any given VMH-
lesioned animal is then seen as a balance between the degree 
of insulin oversecretion (to the point of effective deple-
tion of readily available stores) and the insulin insen-
sitivity engendered by deposition of fat in increasingly 
enlarged cells. 
It is noted that, using this reasoning, any mani-
pulation which decreases food intake (or probably even 
slows the rate of its ingestion) will also reduce the in-
sulin oversecretion problem. This point is critical to the 
VMH "finickiness" question. Here it is argued that an 
animal's tendency initially to consume larger amounts of 
sweet foods and less of bitter would be sufficient to 
... 
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entrain the most severe insulin hypersecretion (leading to 
the hypoglycemia-hyperphagia-hypoglycemia vicious circle) 
in the case of the f ormer and break off this maladaptive 
sequence in the case of bitter substances . For purely 
textural changes the efficacy of any particular diet is 
seen to be related to the ease (i.e ., rate) of its inges-
tion. Given this argument, it becomes of some importance 
to analyze closely the short-term responses (meal size and 
frequency of the initial meals) to changes of palatability 
and texture. 
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APPENDIX A 
F ratios from each of 12 one-way analyses of variance per-
Formed on the data (see Figure 1) of Experiment 1: VMH-
Vagotomy 
Dependent 
Variable 
Insulin 
df = 2 ' 20 
Food Intake 
df = 2 ' 20 
Body Weight 
df = 2 ' 20 
**p < .01 
Weeks fo llowing VMH 
or sham lesion 
1 2 
26.47** 52.03** 
49.31** 20 .4 7** 
86.34** 111.91** 
Weeks following vagotomy 
or sham operation 
1 2 
39.97** 52.88** 
38.11** 10 . 30** 
63.92** 77 . 14** 
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APPENDIX B 
F ratios from each of 12 one-way analyses of variance per-
formed on the data (see Figure 2) of Experiment 2: LHA-
Vagotomy. 
Dependent 
Variable 
Insulin 
df = 2, 20 
Food Intake 
Weeks following LHA or sham 
lesion 
1 2 3 4 
0.27 
df = 2 20 7.10** 
' 
Body Weight 
df = 2, 20 8.67** 9.33** 10.04** 9.01** 
* p < .05 
**p < .01 
Weeks following vagotorny 
or sham operation 
2 4 
1.01 0.64 
6.30** 4.51* 
14.53** 8.22** 
APPENDIX C 
F ratios from each of the 33 one-way analyses of variance performed on the data (see 
Figures 3 and 4) of Experiment 3: LHA-Sympathectomy . 
Dependent 
Variable 
Food Intake 
Weeks after LHA 
lesions or sham 
2 4 
Weeks of GS or saline 
administration 
2 4 6 
Weeks following cessation of treatment 
1 2 3 4 5 6 
df = 3, 32 11.14** 12.76** 9.37** 7.93** 10.00** 7.18** 11.28** 4.61** 9.28** 4.54** 3.41* 
Water Intake 
df = 3 , 32 14.81** 
Body Weight 
df = 3 , 32 8.97** 
* p < .05 
**p < .01 
19.78** 14.91** 9.41** 11.88** 16.09** 10.64**11.70**11.63** 9.26**10.96** 
4.67** 5.00** 7.37** 10.12** 9.93** 12.10** 7 .99**10.18** 9.77** 8.08** 
N 
0 
--..J 
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APP END I X D 
F ratios from each o f the 6 on e-way analyses of variance per-
formed on the data ( s ee Figur e 7) of Experiment 4: VMH 
Insulin Injections. 
Dependent 
Variable 
Blood 
Glucose 
df = 3 ' 
* p < .05 
* *p < . 01 
Time in 
0 
17 0.18 
r-1inutes Following Injec t ions of Insulin 
5 10 20 30 60 
18. 3 0** 4 . 01* 3 . 70 1.88 2 . 79 
APP ENDIX E 
F ratios from each of the 6 on e-way analyses of variance per-
tormed on the data ( see Fi gu r e 8) of Experiment 5 : Ven t ri-
cular Insulin Injections. 
Dependent 
Variable 
Blood 
Gluco s e 
df = 2 ' 
* p < .05 
:'-*p < .01 
Time in 
0 
1 3 0.08 
Minut e s Fo l lowing Injection of Insulin 
5 1 0 20 30 60 
14. 21 ** 6 . 84** 4 . 09* 2.88 1 . 54 
APPENDIX F 
F ratios from each of the 8 one-way analyses of variance performed on the data 
Tsee Figure 13) of Experiment 8: Diabetic Hyperphagia. 
Dependent 
Variable 
Food Intake 
1 
Time in Days F~llow~nE Induction of Diabetes 
2 3 4 6 9 12 15 
df = 4, 32 81.99** 63.65** 48. 46** 46.22** 26.79** 17.91** 40.01** 33.82** 
* *p < . 01 
N 
C) 
~ 
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APPENDIX G 
F ratios from the two-way analysis of variance performed on 
the one-half hour food intake data (see Table 1) of 
Experiment 9: Adrenaline Anorexia and Diabetes. 
Source df F 
Group 2 ' 24 17.92** 
Treatment 2 ' 48 4.76* 
Group X 
Treatment 4 ' 48 14.41** 
* p < . 0 5 
**p < .01 
APPENDIX H 
F ratios from the two-way analysis of variance performed 
on the one-half hour food intake data (see Table 2) of 
Experiment 10: Adrenaline Anorexia and Vagotomy. 
Source df F 
Group 1 ' 12 3.33 
Treatment 2 ' 24 47.94** 
Group X 
Treatment 2 ' 24 1.98 
**p < .01 
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APPE DIX J 
F ratios from the two-way analysis of variance performed on 
the one-half hour food intake data (see Table 3) of 
Experiment 11: Adrenaline Anorexia 
Source df F 
Group 1 ' 10 1.11 
Treatment 2 ' 20 38.47** 
Group X 
Treatment 2 ' 20 0.90 
**p < .01 
APPE DIX K 
F ratios from each of the 2 one-way analyses of variance 
performed on the data (see Table 4) of Experiment 12: 
Estrus Cycle and Insulin. 
*p < • 0 5 
Dependent 
Variable 
Insulin 
df = 2 37 
' 
Glucose 
df = 2 37 
' 
s Group 
3.88* 
0.06 
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APPENDIX L 
F ratios from the one-way analysis of variance performed 
on the data (see Table 5) of Experiment 13: Estrus Cycle 
and Gastric Acid. 
* *p < • 01 
Dependent 
Variable 
Acid secretion 
df = 2, 19 
Groups 
11.80** 
APPENDIX M 
F ratios from each of the 13 one-~ay analyses of variance performed on the data 
Tsee Figures 15 and 16) of Experiment 16: Sympathectomy and Diabetic Intake 
Utilization . · 
Dependent 
Variable 
Food Intake 
df = 3, 26 
Water Intake 
df = 3, 26 
**p < .01 
Pre-treatment 
193.28** 
104. 73** 
Days of Treatment with GS or saline 
3 14-15 21 42 
56.83** 115.40** 90.00** 
93.96** 82.88** 66.74** 119.00** 
Days Post-treatment 
13 14-15 21 
40.97** 76.66** 
90.93** 84.43** 
N 
f---1 
lN 
APPENDIX N 
F ratios from each of the 4 one-way analyses of variance 
performed on the data (see Figure 17B) of Experiment 17: 
Sympathectomy, Ganglionic Block and Blood Glucose . 
Dependent 
214 
Variable Pre-injection Time Following GS or Saline Injection (Hours) 
Blood 
Glucose 
df = 2 13 
' 
* p < . 05 
**p < .01 
0.44 
6 24 72 
33.19** 4.81* 1.03 
APPENDIX P 
F ratios from each of the 2 one-way analyses of variance 
performed on the data (see Tab l e 8) of Experimen t 19: 
Sympathectomy and Diabetic Liver Glycogen. 
* *p < . 01 
Dependent 
Variable 
Liver Weight 
df = 3 , 2 8 
Live r Glycogen 
df = 3, 2 8 
Groups 
12.72** 
17.94** 
